Taussig Cancer Institute 2012 Publications Journal Publications Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr;8(4):445-544.

Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet. 2012 Nov 2;91(5):823-838.

Abaza R, Dangle PP, Gong MC, Bahnson RR, Pohar KS. Quality of lymphadenectomy is equivalent with robotic and open cystectomy using an extended template. J Urol. 2012 Apr;187(4):1200-1205.

Abdel-Wahab M, Mahmoud O, Merrick G, Hsu ICJ, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Jr., Yamada Y. ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer. J Am Coll Radiol. 2012 Apr;9(4):233-238.

Abdel-Wahab M, Schally AV, Rick FG, Szalontay L, Block NL, Jorda M, Mahmoud O, Markoe A, Shi YF, Reiner T, Zarandi M, Duncan R. Antagonists of growth hormone releasing hormone (GHRH) given before whole body radiation lead to modulation of radiation response and organ-specific changes in the expressionof angiogenesis. J Radiat Oncol. 2012 Dec;1(4):389-396.

Aboua YG, Brooks N, Mahfouz RZ, Agarwal A, Du Plessis SS. A red palm oil diet can reduce the effects of oxidative stress on rat spermatozoa. Andrologia. 2012 May;44 Suppl 1:32-40.

Abraham J, Chua YX, Glover JM, Tyner JW, Loriaux MM, Kilcoyne A, Giles FJ, Nelon LD, Carew JS, Ouyang Y, Michalek JE, Pal R, Druker BJ, Rubin BP, Keller C. An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma. Biochem Biophys Res Commun. 2012 Sep 28;426(3):363-368.

Adelstein DJ. Clinical trial design in head and neck cancer: what has the oncologist learned? Lancet Oncol. 2012 Jul;13(7):e318-e323.

Adelstein DJ, Koyfman SA, El-Naggar AK, Hanna EY. Biology and management of salivary gland cancers. Semin Radiat Oncol. 2012 Jul;22(3):245-253.

Adelstein DJ, Ridge JA, Brizel DM, Holsinger FC, Haughey BH, O'Sullivan B, Genden EM, Beitler JJ, Weinstein GS, Quon H, Chepeha DB, Ferris RL, Weber RS, Movsas B, Waldron J, Lowe V, Ramsey S, Manola J, Yueh B, Carey TE, Bekelman JE, Konski AA, Moore E, Forastiere A, Schuller DE, Lynn J, Ullmann CD. Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck. 2012 Dec;34(12):1681-1703.

Adelstein DJ, Rodriguez CP, Rybicki LA, Ives DI, Rice TW. A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction. Invest New Drugs. 2012 Aug;30(4):1684-1689.

Agyeman A, Mazumdar T, Houghton JA. Regulation of DNA damage following termination of Hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer. Oncotarget. 2012 Aug;3(8):851-865.

Ahluwalia MS, Wallace PK, Peereboom DM. Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: Ready for prime time? Cancer. 2012 Apr 1;118(7):1747-1753.

Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, Saiakhova A, Bartels CF, Balasubramanian D, Myeroff L, Lutterbaugh J, Jarrar A, Kalady MF, Willis J, Moore JH, Tesar PJ, Laframboise T, Markowitz S, Lupien M, Scacheri PC. Epigenomic enhancer profiling defines a signature of colon cancer. Science. 2012 May 11;336(6082):736-739.

Aktas A, Walsh D, Rybicki L. Symptom clusters and prognosis in advanced cancer. Support Care Cancer. 2012 Nov;20(11):2837-2843.

Alcazar O, Achberger S, Aldrich W, Hu Z, Negrotto S, Saunthararajah Y, Triozzi P. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo. Int J Cancer. 2012 Jul 1;131(1):18-29.

Aldred MA, Morrell NW. Waiting in anticipation: the genetics of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012 Nov 1;186(9):820-821.

Alghoul M, Mendiola A, Seth R, Rubin BP, Zins JE, Calabro A, Siemionow M, Kusuma S. The effect of hyaluronan hydrogel on fat graft survival. Aesthet Surg J. 2012 Jul;32(5):622-633.

Alhaddad B, Saad NA, Daw HA, Setrakian S, Haddad A. Malignant pleural mesothelioma presenting as rectal polyp: a case report and review of the literature. Gastrointest Cancer Res. 2012 Sep;5(5):174-176.

Allen KL, Fonseca FV, Betapudi V, Willard B, Zhang J, McCrae KR. A novel pathway for human endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood. 2012 Jan 19;119(3):884-893.

Alraiyes AH, Alraies MC, Almeida FA, Singh AD. Flashing lights, floaters, and reduced vision. Cleve Clin J Med. 2012 Sep;79(9):616-618.

Ananthakrishnan P, Balci FL, Crowe JP. Optimizing surgical margins in breast conservation. Int J Surg Oncol. 2012;2012:585670.

Ang SK, LeGrand SB, Walsh D, Davis MP, Lagman RL. Physician home visits by palliative medicine fellow. Am J Hosp Palliat Care. 2012 Mar;29(2):112-115.

Ankerst DP, Boeck A, Freedland SJ, Thompson IM, Cronin AM, Roobol MJ, Hugosson J, Jones JS, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schroder FH, Lilja H,

Vickers AJ. Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World J Urol. 2012 Apr;30(2):181-187.

Archacki SR, Angheloiu G, Moravec CS, Liu H, Topol EJ, Wang QK. Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease. Hum Mol Genet. 2012 Mar 15;21(6):1364-1373.

Aron M, Gill IS, Campbell SC. A nonischemic approach to partial nephrectomy is optimal. J Urol. 2012 Feb;187(2):387-390.

Aronow M, Sun Y, Saunthararajah Y, Biscotti C, Tubbs R, Triozzi P, Singh AD. Monosomy 3 by FISH in uveal melanoma: Variability in techniques and results. Surv Ophthalmol. 2012 Sep-Oct;57(5):463-473.

Aronow ME, Nakagawa JA, Gupta A, Traboulsi EI, Singh AD. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings. Ophthalmology. 2012 Sep;119(9):1917-1923.

Aronow ME, Adamus G, Abu-Asab M, Wang Y, Chan CC, Zakov ZN, Singh AD. Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature. Surv Ophthalmol. 2012 Nov-Dec;57(6):558-564.

Ashida S, Orloff MS, Bebek G, Zhang L, Zheng P, Peehl DM, Eng C. Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes. Clin Cancer Res. 2012 Mar 15;18(6):1578-1587.

Asosingh K, Farha S, Lichtin A, Graham B, George D, Aldred M, Hazen SL, Loyd J, Tuder R, Erzurum SC. Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension. Blood. 2012 Aug 9;120(6):1218-1227.

Attia A, Tatter SB, Weller M, Marshall K, Lovato JF, Bourland JD, Ellis TL, McMullen KP, Shaw EG, Chan MD. CT-only planning for Gamma Knife radiosurgery in the treatment of trigeminal neuralgia: Methodology and outcomes from a single institution. J Med Imaging Radiat Oncol. 2012 Aug;56(4):490-494.

Avallone AN, Avallone MA, Share S, Rubin BP. Epithelioid hemangioma-a rare scrotal tumor of childhood. Urology. 2012 Sep;80(3):707-709.

Babsky AM, Ju S, Bennett S, George B, McLennan G, Bansal N. Effect of implantation site and growth of hepatocellular carcinoma on apparent diffusion coefficient of water and sodium MRI. NMR Biomed. 2012 Feb;25(2):312-321.

Baker ME, Dong F, Primak A, Obuchowski NA, Einstein D, Gandhi N, Herts BR, Purysko A, Remer E, Vachani N. Contrast-to-noise ratio and low-contrast object resolution on full- and low-dose MDCT: SAFIRE versus filtered back projection in a low-contrast object phantom and in the liver. AJR Am J Roentgenol. 2012 Jul;199(1):8-18.

Balagamwala EH, Chao ST, Suh JH. Principles of radiobiology of stereotactic radiosurgery and clinical applications in the central nervous system. Technol Cancer Res Treat. 2012 Feb;11(1):3-13.

Balagamwala EH, Cherian S, Angelov L, Suh JH, Djemil T, Lo SS, Sahgal A, Chang E, Teh BS, Chao ST. Stereotactic body radiotherapy for the treatment of spinal metastases. J Radiat Oncol. 2012 Sep;1(3):255-265.

Balagamwala EH, Angelov L, Koyfman SA, Suh JH, Reddy CA, Djemil T, Hunter GK, Xia P, Chao ST. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine. 2012 Dec;17(6):556-564.

Balagamwala EH, Suh JH, Barnett GH, Khan MK, Neyman G, Cai RS, Vogelbaum MA, Novak E, Chao ST. The importance of the conformality, heterogeneity, and gradient indices in evaluating Gamma Knife radiosurgery treatment plans for intracranial meningiomas. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1406-1413.

Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers TA, Jr., Lustberg MB, Zborowski M, Chalmers JJ. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS One. 2012;7(7):e42048.

Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biol Blood Marrow Transplant. 2012 Sep;18(9):1446-1454.

Baranek C, Dittrich M, Parthasarathy S, Bonnon CG, Britanova O, Lanshakov D, Boukhtouche F, Sommer JE, Colmenares C, Tarabykin V, Atanasoski S. Protooncogene Ski cooperates with the chromatin-remodeling factor Satb2 in specifying callosal neurons. Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3546-3551.

Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, Vogelbaum MA, Sperduto PW, Mehta MP, Machtay M, Kattan MW. A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol. 2012 Jul;14(7):910-918.

Bastian PJ, Boorjian SA, Bossi A, Briganti A, Heidenreich A, Freedland SJ, Montorsi F, Roach M, III, Schroder F, van Poppel H, Stief CG, Stephenson AJ, Zelefsky MJ. High-risk prostate cancer: from definition to contemporary management. Eur Urol. 2012 Jun;61(6):1096-1106.

Basyigit I, Okumus G, Erzurum S, Asosingh K, Papakosta D. Pulmonary hypertension. Pulm Med. 2012;2012:893157.

Bauer EM, Shapiro R, Zheng H, Ahmad F, Ishizawar D, Comhair SA, Erzurum SC, Billiar TR, Bauer PM. High mobility group box 1 contributes to the pathogenesis of

experimental pulmonary hypertension via activation of toll-like receptor 4. Mol Med. 2012;18:1509-1518.

Beall CM, Laskowski D, Erzurum SC. Nitric oxide in adaptation to altitude. Free Radic Biol Med. 2012 Apr 1;52(7):1123-1134.

Bebek G, Bennett KL, Funchain P, Campbell R, Seth R, Scharpf J, Burkey B, Eng C. Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma. Hum Mol Genet. 2012 Apr 1;21(7):1557-1565.

Bejanyan N, Bolwell BJ, Lazaryan A, Rybicki L, Tench S, Duong H, Andresen S, Sobecks R, Dean R, Pohlman B, Kalaycio M, Copelan EA. Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT). Biol Blood Marrow Transplant. 2012 Jun;18(6):874-880.

Bejanyan N, Tiu RV, Raza A, Jankowska A, Kalaycio M, Advani A, Chan J, Saunthararajah Y, Mooney L, Maciejewski JP, Sekeres MA. A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF). Cancer. 2012 Aug 15;118(16):3968-3976.

Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TCK, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JAZ. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug;143(2):336-346.

Bentley AA, Merkulov SM, Peng Y, Rozmarynowycz R, Qi X, Pusztai-Carey M, Merrick WC, Yee VC, McCrae KR, Komar AA. Chimeric glutathione S-transferases containing inserts of kininogen peptides: Potential novel protein therapeutics. J Biol Chem. 2012 Jun 22;287(26):22142-22150.

Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White R, Hemstreet GP, III, Crawford ED, Thompson IM, Jr., Klein EA. Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: Update on Southwest Oncology Group study 9109. Urology. 2012 Mar;79(3):633-637.

Berglund RK, Zaytoun O, Thousand R, Stephans K, Tendulkar R, Klein EA, Jones JS. Early infectious complications with transponder placement for external beam radiation therapy for prostate cancer. BJU Int. 2012 Sep;110(6):834-838.

Bienes-Martinez R, Ordonez A, Feijoo-Cuaresma M, Corral-Escariz M, Mateo G, Stenina O, Jimenez B, Calzada MJ. Autocrine stimulation of clear-cell renal carcinoma cell migration in hypoxia via HIF-independent suppression of thrombospondin-1. Sci Rep. 2012;2:788.

Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organiz J. 2012 Jan;5(1):9-19.

Biscotti CV, Singh AD. Uveal metastases. Monogr Clin Cytol. 2012;21:17-30.

Biscotti CV, Singh AD. Uveal melanoma: diagnostic features. Monogr Clin Cytol. 2012;21:44-54.

Biscotti CV, Singh AD. Preface [FNA cytology of ophthalmic tumors]. Monogr Clin Cytol. 2012;21:viii.

Borden EC, Dowlati A. Phase I trials of targeted anticancer drugs: a need to refocus. Nat Rev Drug Discov. 2012 Nov 30;11(12):889-890.

Bose P, Perkins EB, Honeycut C, Wellons MD, Stefan T, Jacobberger JW, Kontopodis E, Beumer JH, Egorin MJ, Imamura CK, Figg WD, Sr., Karp JE, Koc ON, Cooper BW, Luger SM, Colevas AD, Roberts JD, Grant S. Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl(+) hematological malignancies. Cancer Chemother Pharmacol. 2012 Jun;69(6):1657-1667.

Brady A, Gibson S, Rybicki L, Hsi E, Saunthararajah Y, Sekeres MA, Tiu R, Copelan E, Kalaycio M, Sobecks R, Bates J, Advani AS. Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia. Eur J Haematol. 2012 Oct;89(4):288-293.

Brooks S, Djohan R, Tendulkar R, Nutter B, Lyons J, Dietz J. Risk factors for complications of radiation therapy on tissue expander breast reconstructions. Breast J. 2012 Jan-Feb;18(1):28-34.

Bucur O, Stancu AL, Khosravi-Far R, Almasan A. Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications. Cell Death Dis. 2012;3:e263.

Budd GT. Circulating tumor cells in biliary cancer: First step or false step? J Gastrointest Oncol. 2012 Jun;3(2):82-83.

Bukowski RM. Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinoma. Front Oncol. 2012;2:13.

Bukowski RM. Temsirolimus : a safety and efficacy review. Expert Opin Drug Saf. 2012 Sep;11(5):861-879.

Burke CA. Number needed to screen to detect adenomas, advanced adenomas and colorectal cancer is higher in women than in similarly aged men. Evid Based Med. 2012 Oct;17(5):159-160.

Burke CA, Snover DC. Editorial: Sessile serrated adenomas and their pit patterns: We must first see the forest through the trees. Am J Gastroenterol. 2012 Mar;107(3):470-472.

Campbell SC. A nonischemic approach to partial nephrectomy is optimal. No. J Urol. 2012 Feb;187(2):388-390.

Campbell SC, Cookson MS. The Oncology Knowledge Assessment Test. Urol Oncol. 2012 May-Jun;30(3):235.

Campbell SC. Re: a prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2012 Sep;62(3):564-565.

Campbell SC. Editorial comment [Understanding the role of percutaneous biopsy in the management of patients with a small renal mass]. Urology. 2012 Feb;79(2):377-378.

Campbell SC, Simmons M. Editorial comment [Zero ischemia anatomical partial nephrectomy: A novel approach]. J Urol. 2012 Mar;187(3):814.

Campbell SC. Editorial comment [Factors affecting renal function after open partial nephrectomy-a comparison of clampless and clamped warm ischemic technique]. Urology. 2012 Oct;80(4):870-871.

Caralla T, Boehm C, Hascall V, Muschler G. Hyaluronan as a novel marker for rapid selection of connective tissue progenitors. Ann Biomed Eng. 2012 Dec;40(12):2559-2567.

Chakrabarti A, Ghosh PK, Banerjee S, Gaughan C, Silverman RH. Rnase L triggers autophagy in response to viral infections. J Virol. 2012 Oct;86(20):11311-11321.

Chan ESY, Patel AR, Hansel DE, Larchian WA, Heston WD. Sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model. Urology. 2012 Sep;80(3):736-5.

Chang SS, Dinney CPN, Donat SM, Dahm P, Gore JL, Lotan Y, Parekh DJ, Solit DB, O'Donnell PH, Feng FY, Hansel D, Milowsky MI. 12th Annual Meeting of the Society of Urologic Oncology (SUO) Bladder Cancer Sessions I and II summary report. Urol Oncol. 2012 Nov-Dec;30(6):944-947.

Chao ST, Koyfman SA, Woody N, Angelov L, Soeder SL, Reddy CA, Rybicki LA, Djemil T, Suh JH. Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1738-1743.

Chao ST, Thakkar VV, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Rasmussen P, Reuther AM, Jamison B, Neyman G, Suh JH. Prospective study of the short-term adverse effects of gamma knife radiosurgery. Technol Cancer Res Treat. 2012 Apr;11(2):117-122.

Cheng V, Faiman C, Kennedy L, Khoury F, Hatipoglu B, Weil R, Hamrahian A. Pregnancy and acromegaly: a review. Pituitary. 2012 Mar;15(1):59-63.

Cheriyath V, Kuhns MA, Jacobs BS, Evangelista P, Elson P, Downs-Kelly E, Tubbs R, Borden EC. G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer. Oncogene. 2012 Apr 26;31(17):2222-2236.

Chin BB, Hjelemand A, Rich J, Song H, Lascola C, Storms R, McLendon R, Reiman R, Greer KL, Metzler SD, McDougald D, Dai D, Vaidyanathan G. Synthesis and preliminary evaluation of n.c.a. iodoquine: A novel radiotracer with high uptake in cells with high ALDH1 expression. Curr Radiopharm. 2012 Jan 1;5(1):47-58.

Church J, Heald B, Burke C, Kalady M. Understanding MYH-associated neoplasia. Dis Colon Rectum. 2012 Mar;55(3):359-362.

Chute DJ, Biscotti CV, Singh AD. Uveal lymphoma. Monogr Clin Cytol. 2012;21:31-43.

Ciezki JP, Reddy CA. Editorial comment [Results of a surgically derived nomogram to predict gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapy]. Urology. 2012 Sep;80(3):654.

Ciezki JP, Reddy CA, Kupelian PA, Klein EA. Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis. Urology. 2012 Aug;80(2):367-373.

Ciezki JP, Reddy CA, Kupelian PA, Klein EA. Reply [Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis]. Urology. 2012 Aug;80(2):373.

Ciezki JP, Hsu ICJ, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria((R)) - Locally advanced (high-risk) prostate cancer. Clin Oncol (R Coll Radiol ). 2012 Feb;24(1):43-51.

Cines DB, McCrae KR, Zheng XL, Sachais BS, Luning Prak ET, Siegel DL. Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders. Blood. 2012 Nov 15;120(20):4134-4142.

Cohen PA, Ko JS, Storkus WJ, Spencer CD, Bradley JM, Gorman JE, McCurry DB, Zorro-Manrique S, Dominguez AL, Pathangey LB, Rayman PA, Rini BI, Gendler SJ, Finke JH. Myeloid-derived suppressor cells adhere to physiologic STAT3-vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape. Immunol Invest. 2012;41(6-7):680-710.

Collie AMB, Hsi ED. Molecular characteristics of diffuse large B-cell lymphoma, not otherwise specified. Pathology Case Reviews. 2012 Mar;17(2):41-51.

Comhair SAA, Xu W, Mavrakis L, Aldred MA, Asosingh K, Erzurum SC. Human primary lung endothelial cells in culture. Am J Respir Cell Mol Biol. 2012 Jun;46(6):723-730.

Cook RJ, Wang Z, Arora M, Lazarus HM, Kasow KA, Champagne MA, Saber W, van Besien KM, Hale GA, Copelan EA, Elmongy M, Ueno NT, Horn BN, Slavin S, Bishop MR, Stadtmauer EA. Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis. Bone Marrow Transplant. 2012 Nov;47(11):1455-1458.

Cooney MM, Nock C, Bokar J, Krishnamurthi S, Gibbons J, Rodal MB, Ness A, Remick SC, Dreicer R, Dowlati A. Phase I trial of pomalidomide given for patients with advanced solid tumors. Cancer Chemother Pharmacol. 2012 Nov;70(5):755-761.

Cross BCS, Bond PJ, Sadowski PG, Jha BK, Zak J, Goodman JM, Silverman RH, Neubert TA, Baxendale IR, Ron D, Harding HP. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):E869-E878.

Culligan K, Coffey JC, Kiran RP, Kalady M, Lavery IC, Remzi FH. The mesocolon: a prospective observational study. Colorectal Dis. 2012 Apr;14(4):421-428.

Czuczman MS, Leonard JP, Jung S, Johnson JL, Hsi ED, Byrd JC, Cheson BD. Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness. Ann Oncol. 2012 Sep;23(9):2356-2362.

D'Ambrosio DJ, Bayouth J, Chetty IJ, Buyyounouski MK, Price RA, Correa CR, Dilling TJ, Franklin GE, Xia P, Harris EER, Konski A. Continuous localization technologies for radiotherapy delivery: Report of the American Society for Radiation Oncology Emerging Technology Committee. Pract Radiat Oncol. 2012 Apr;2(2):145-150.

Dahiya S, Ooi WB, Ahluwalia MS, Asik A. Primary central nervous system posttransplantation lymphoproliferative disorder in an elderly liver transplant recipient. J Am Geriatr Soc. 2012 Sep;60(9):1777-1778.

Das Gupta J, Luk KC, Tang N, Gaughan C, Klein EA, Kandel ES, Hackett J, Jr., Silverman RH. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1. PLoS One. 2012;7(5):e36072.

Davis M, Lasheen W, Walsh D, Mahmoud F, Bicanovsky L, Lagman R. A phase II dose titration study of thalidomide for cancer-associated anorexia. J Pain Symptom Manage. 2012 Jan;43(1):78-86.

Davis MP. The emerging role of palliative medicine in the treatment of lung cancer patients. Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS51-eS55.

Davis MP, Mitchell GK. Topics in research: structuring studies in palliative care. Curr Opin Support Palliat Care. 2012 Dec;6(4):483-489.

Davis MP, Mitchell G. Reconstructing analgesic trials: reasons for following the lead of oncologists. Curr Opin Support Palliat Care. 2012 Dec;6(4):490-493.

Davis MP. Drug management of visceral pain: concepts from basic research. Pain Res Treat. 2012;2012:265605.

Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012 Nov-Dec;10(6):209-219.

Davis MP. Are there cost benefits to fentanyl for breakthrough pain? J Pain Symptom Manage. 2012 Sep;44(3):e1-e2.

Davis MP. Evidence from basic research for opioid combinations. Expert Opin Drug Discov. 2012 Feb;7(2):165-178.

de Campos-Lobato LF, Dietz DW, Stocchi L, Vogel JD, Lavery IC, Goldblum JR, Skacel M, Pelley RJ, Kalady MF. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation. Colorectal Dis. 2012 Jan;14(1):62-67.

de Herder WW, Eng C. Obesity, diabetes mellitus, and cancer. Endocr Relat Cancer. 2012;19(5):E5-E7.

Deer TR, Levy R, Prager J, Buchser E, Burton A, Caraway D, Cousins M, De Andres J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, Mcdowell GC, Panchal S, Rauck R, Saulino M, Sitzman BT, Staats P, Stanton-Hicks M, Stearns L, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N. Polyanalgesic consensus conference-2012: Recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain. Neuromodulation. 2012 Sep-Oct;15(5):467-482.

Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, Caraway D, Cousins M, De Andres J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, Mcdowell GC, Panchal S, Rauck R, Saulino M, Sitzman BT, Staats P, Stanton-Hicks M, Stearns L, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N. Polyanalgesic consensus conference-2012: Consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses). Neuromodulation. 2012 Sep-Oct;15(5):483-496.

Deer TR, Prager J, Levy R, Burton A, Buchser E, Caraway D, Cousins M, De Andres J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs M, Kim P, Kumar K, Leong M, Liem L, McDowell G, Panchal SJ, Rauck R, Saulino M, Staats P, Stanton-Hicks M, Stearns L, Sitzman BT, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N. Polyanalgesic consensus conference-2012: Recommendations on trialing for intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation. 2012 Sep-Oct ;15(5):420-435.

Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, Caraway D, Cousins M, De Andres J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, Mcdowell GC, II, Panchal S, Rauck R, Saulino M, Sitzman BT, Staats P, Stanton-Hicks M, Stearns L, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N. Polyanalgesic consensus conference 2012: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation. 2012 Sep-Oct;15(5):436-466.

Deschamps AM, Eng C. Engaging basic scientists in translational research. Endocr Relat Cancer. 2012 Jun;19(3):E1-E3.

Despotovic JM, Lambert MP, Herman JH, Gernsheimer TB, McCrae KR, Tarantino MD, Bussel JB. RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME). Transfusion. 2012 May;52(5):1126-1136.

Devarajan J, Byrd JB, Gong MC, Wood HM, O'Hara J, Weingarten TN, Warner MA, Warner ME, Sprung J. Upper and middle trunk brachial plexopathy after robotic prostatectomy. Anesth Analg. 2012 Oct;115(4):867-870.

Dewhurst C, Rosen MP, Blake MA, Baker ME, Cash BD, Fidler JL, Greene FL, Hindman NM, Jones B, Katz DS, Lalani T, Miller FH, Small WC, Sudakoff GS, Tulchinsky M, Yaghmai V, Yee J. ACR Appropriateness Criteria® pretreatment staging of colorectal cancer. J Am Coll Radiol. 2012 Nov;9(11):775-781.

DiFilippo FP, Patel S, Asosingh K, Erzurum SC. Small-animal imaging using clinical positron emission tomography/computed tomography and super-resolution. Mol Imaging. 2012 May-Jun;11(3):210-219.

Digiorgio MJ, Fatica C, Oden M, Bolwell B, Sekeres M, Kalaycio M, Akins P, Shane C, Bako J, Gordon SM, Fraser TG. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2012 Sep;33(9):865-868.

Ding L, Biswas S, Morton RE, Smith JD, Hay N, Byzova TV, Febbraio M, Podrez EA. Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. Cell Metab. 2012 Jun 6;15(6):861-872.

Doerr M, Eng C. Personalised care and the genome. BMJ. 2012;344:e3174.

Dreicer R. Sequencing of therapies in advanced prostate cancer. Oncology (Williston Park). 2012 Jan;26(1):82, 84.

Dreicer R. The future of drug development in urothelial cancer. J Clin Oncol. 2012 Feb 10;30(5):473-475.

Dreicer R. Systemic therapy for advanced adrenal cancer. J Surg Oncol. 2012 Oct 1;106(5):643-646.

Dumont AG, Rink L, Godwin AK, Miettinen M, Joensuu H, Strosberg JR, Gronchi A, Corless CL, Goldstein D, Rubin BP, Maki RG, Lazar AJ, Lev D, Trent JC, von Mehren M. A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. Ann Oncol. 2012 May;23(5):1335-1340.

Ebrahem Q, Mahfouz RZ, Ng KP, Saunthararajah Y. High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects. Oncotarget. 2012 Oct;3(10):1137-1145.

El-Telbany A, Ma PC. Cancer genes in lung cancer: racial disparities: are there any? Genes Cancer. 2012 Jul;3(7-8):467-480.

Ergin AB, Fong N, Daw HA. Rituximab-induced bronchiolitis obliterans organizing pneumonia. Case Rep Med. 2012;2012:680431.

Erzurum SC, Gaston BM. Biomarkers in asthma: a real hope to better manage asthma. Clin Chest Med. 2012 Sep;33(3):459-471.

Eyler CE, Rich JN. Looking in the miR-ror: TGF-beta-mediated activation of NF-kappaB in glioma. J Clin Invest. 2012 Oct 1;122(10):3473-3475.

Fahed E, Hansel DE, Raghavan D, Quinn DI, Dorff TB. Small cell bladder cancer: biology and management. Semin Oncol. 2012 Oct;39(5):615-618.

Faiman B, Miceli TS, Richards T, Tariman JD. Survey of experiences of an e-mentorship program: Part II. Clin J Oncol Nurs. 2012 Feb 1;16(1):50-54.

Fan C, Gaivin RJ, Marth TA, Willard B, Levine MA, Lietman SA. Cloning and characterization of the human SH3BP2 promoter. Biochem Biophys Res Commun. 2012 Aug 17;425(1):25-32.

Fang X, Wang C, Balgley BM, Zhao K, Wang W, He F, Weil RJ, Lee CS. Targeted tissue proteomic analysis of human astrocytomas. J Proteome Res. 2012 Aug 3;11(8):3937-3946.

Farha S, Sharp J, Asosingh K, Park M, Comhair SAA, Tang WHW, Thomas J, Farver C, Hsieh F, Loyd JE, Erzurum SC. Mast cell number, phenotype, and function in human pulmonary arterial hypertension. Pulm Circ. 2012 Apr-Jun;2(2):220-228.

Fawole A, Daw H, Taylor H, Rashidi A. Immunoglobulin A nephropathy associated with mesothelioma. WMJ. 2012 Feb;111(1):29-32.

Feng Y, Thiagarajan PS, Ma PC. MET signaling: Novel targeted inhibition and its clinical development in lung cancer. J Thorac Oncol. 2012 Feb;7(2):459-467.

Feng Y, Ma PC. MET targeted therapy for lung cancer: Clinical development and future directions. Lung Cancer: Targets and Therapy. 2012;3:53-67.

Fine SW, Amin MB, Berney DM, Bjartell A, Egevad L, Epstein JI, Humphrey PA, Magi-Galluzzi C, Montironi R, Stief C. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. Eur Urol. 2012 Jul;62(1):20-39.

Flechner SM, Campbell SC. The use of kidneys with small renal tumors for transplantation: who is taking the risk? Am J Transplant. 2012 Jan;12(1):48-54.

Forero-Torres A, De Vos S, Pohlman BL, Pashkevich M, Cronier DM, Dang NH, Carpenter SP, Allan BW, Nelson JG, Slapak CA, Smith MR, Link BK, Wooldridge JE, Ganjoo KN. Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcgammaRIIIa-genotyped patients with previously treated follicular lymphoma. Clin Cancer Res. 2012 Mar 1;18(5):1395-1403.

Frazier TW, Youngstrom EA, Speer L, Embacher R, Law P, Constantino J, Findling RL, Hardan AY, Eng C. Validation of proposed DSM-5 criteria for autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):28-40.

Freire M, Rubin B, Lietman S, Sundaram M. Solitary glomus tumor recurring as multiple glomus tumors. Skeletal Radiol. 2012 Oct;41(10):1333-1337.

Fritchie KJ, Carver P, Sun Y, Batiouchko G, Billings SD, Rubin BP, Tubbs RR, Goldblum JR. Solitary fibrous tumor: is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? Am J Clin Pathol. 2012 Jun;137(6):963-970.

Fritchie KJ, Goldblum JR, Tubbs RR, Sun Y, Carver P, Billings SD, Rubin BP. The expanded histologic spectrum of myxoid liposarcoma with an emphasis on newly described patterns: implications for diagnosis on small biopsy specimens. Am J Clin Pathol. 2012 Feb;137(2):229-239.

Galanis E, Wu W, Cloughesy T, Lamborn K, Mann B, Wen PY, Reardon DA, Wick W, MacDonald D, Armstrong TS, Weller M, Vogelbaum M, Colman H, Sargent DJ, van den Bent MJ, Gilbert M, Chang S. Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. Lancet Oncol. 2012 May;13(5):e196-e204.

Galsky MD, Chen GJ, Oh WK, Bellmunt J, Roth BJ, Petrioli R, Dogliotti L, Dreicer R, Sonpavde G. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Ann Oncol. 2012 Feb;23(2):406-410.

Garcia JA, Mekhail T, Elson P, Wood L, Bukowski RM, Dreicer R, Rini BI. Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-alpha in patients with metastatic renal cell carcinoma. BJU Int. 2012 Jan;109(1):63-69.

Garcia JA, Rini BI. Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead. Cancer. 2012 May 15;118(10):2583-2593.

Garg A, Herts BR. Birt-Hogg-Dube syndrome. J Urol. 2012 Oct;188(4):1343-1344.

Germing U, Lauseker M, Hildebrandt B, Symeonidis A, Cermak J, Fenaux P, Kelaidi C, Pfeilstocker M, Nosslinger T, Sekeres M, Maciejewski J, Haase D, Schanz J, Seymour J, Kenealy M, Weide R, Lubbert M, Platzbecker U, Valent P, Gotze K, Stauder R, Blum S, Kreuzer KA, Schlenk R, Ganser A, Hofmann WK, Aul C, Krieger O, Kundgen A, Haas R, Hasford J, Giagounidis A. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study. Leukemia. 2012 Jun;26(6):1286-1292.

Ghosh PS, Shah SN, Mitra S. Knee MRI showing thickened peripheral nerves in Charcot-Marie-Tooth disease. Acta Neurol Belg. 2012 Sep;112(3):315-316.

Ghosh PS, Tekautz T, Mitra S. Pearls & Oy-sters: Bifocal germinoma of the brain: review of systems is key to the diagnosis. Neurology. 2012 Jan 10;78(2):e8-e10.

Ghosh S, Erzurum SC. Modulation of asthma pathogenesis by nitric oxide pathways and therapeutic opportunities. Drug Discov Today Dis Mech. 2012 Dec 1;9(3-4):e89-e94.

Gillet JP, Calcagno AM, Varma S, Davidson B, Bunkholt Elstrand M, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM. Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma. Clin Cancer Res. 2012 Jun 1;18(11):3197-3206.

Gilligan T. Is there such a thing as a cancer treatment that isn't worth its cost? Oncologist. 2012;17(1):3-4.

Gilligan T. If I paint a rosy picture, will you promise not to cry? J Clin Oncol. 2012 Sep 20;30(27):3421-3423.

Ginat DT, Singh AD, Moonis G. Multimodality imaging of hydrogel scleral buckles. Retina. 2012 Sep;32(8):1449-1452.

Goc A, Liu J, Byzova TV, Somanath PR. Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin beta(3) affinity modulation. Br J Cancer. 2012 Aug 7;107(4):713-723.

Godley A, Ahunbay E, Peng C, Li XA. Accumulating daily-varied dose distributions of prostate radiation therapy with soft-tissue-based kV CT guidance. J Appl Clin Med Phys. 2012;13(3):98-107.

Goenka AH, Shah SN, Remer EM. Imaging of the retroperitoneum. Radiol Clin North Am. 2012 Mar;50(2):333-355.

Goenka AH, Shah SN, Remer EM, Berber E. Adrenal imaging: A primer for oncosurgeons. J Surg Oncol. 2012 Oct 1;106(5):543-548.

Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SMM, Miyazaki Y, Pfeilstocker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012 Sep 20;120(12):2454-2465.

Gromova P, Rubin BP, Thys A, Cullus P, Erneux C, Vanderwinden JM. ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours. J Cell Mol Med. 2012 Feb;16(2):306-317.

Grossman SA, Ye X, Peereboom D, Rosenfeld MR, Mikkelsen T, Supko JG, Desideri S. Phase I study of terameprocol in patients with recurrent high-grade glioma. Neuro Oncol. 2012 Apr;14(4):511-517.

Gruver AM, Amin MB, Luthringer DJ, Westfall D, Arora K, Farver CF, Osunkoya AO, McKenney JK, Hansel DE. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated

invasive squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012 Nov;136(11):1339-1346.

Gruver AM, Huba MA, Dogan A, Hsi ED. Fibrin-associated large B-cell lymphoma: Part of the spectrum of cardiac lymphomas. Am J Surg Pathol. 2012 Oct;36(10):1527-1537.

Gu X, Neric NJ, Crabb JS, Crabb JW, Bhattacharya SK, Rayborn ME, Hollyfield JG, Bonilha VL. Age-related changes in the retinal pigment epithelium (RPE). PLoS One. 2012;7(6):e38673.

Guo S, Reddy CA, Chao ST, Suh JH, Barnett GH, Vogelbaum MA, Videtic GM. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases. Lung Cancer. 2012 Aug;77(2):389-393.

Guo S, Reddy CA, Kolar M, Woody N, Mahadevan A, Deibel FC, Dietz DW, Remzi FH, Suh JH. Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland Clinic experience. Radiat Oncol. 2012;7:110.

Gupta M, Suh TT. Collagenous colitis in a patient with chronic diarrhea: An underdiagnosed and undertreated condition. Clin Geriatr. 2012 Sep;120(9):20-26.

Gupta R, Billis A, Shah RB, Moch H, Osunkoya AO, Jochum W, Hes O, Bacchi CE, de Castro MG, Hansel DE, Zhou M, Vankalakunti M, Salles PG, Cabrera RA, Gown AM, Amin MB. Carcinoma of the collecting ducts of bellini and renal medullary carcinoma: Clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol. 2012 Sep;36(9):1265-1278.

Haddad H, Rini BI. Current treatment considerations in metastatic renal cell carcinoma. Curr Treat Options Oncol. 2012 Jun;13(2):212-229.

Haddad H, Garcia JA. Novel agents for the management of castration-resistant prostate cancer. Curr Opin Urol. 2012 May;22(3):175-182.

Hale GA, Shrestha S, Le-Rademacher J, Burns LJ, Gibson J, Inwards DJ, Freytes CO, Bolwell BJ, Hsu JW, Slavin S, Isola L, Rizzieri DA, Gale RP, Laport GG, Montoto S, Lazarus HM, Hari PN. Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR. Biol Blood Marrow Transplant. 2012 Jul;18(7):1036-1043.e1.

Hallahan KM, Sood A, Singh AD. Acute episode of eyelid oedema. Br J Ophthalmol. 2012 Jun;96(6):909, 913.

Hama A, Muramatsu H, Makishima H, Sugimoto Y, Szpurka H, Jasek M, O'Keefe C, Takahashi Y, Sakaguchi H, Doisaki S, Shimada A, Watanabe N, Kato K, Kiyoi H, Naoe T, Kojima S, Maciejewski JP. Molecular lesions in childhood and adult acute megakaryoblastic leukaemia. Br J Haematol. 2012 Feb;156(3):316-325.

Hamerlik P, Lathia JD, Rasmussen R, Wu Q, Bartkova J, Lee M, Moudry P, Bartek J, Jr., Fischer W, Lukas J, Rich JN, Bartek J. Autocrine VEGF-VEGFR2-Neuropilin-1 signaling

promotes glioma stem-like cell viability and tumor growth. J Exp Med. 2012 Mar 12;209(3):507-520.

Hamilton BK, Copelan EA. Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia. Stem Cells. 2012 Aug;30(8):1581-1586.

Harshman LC, Xie W, Bjarnason GA, Knox JJ, Mackenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DYC, Choueiri TK. Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol. 2012 Sep;13(9):927-935.

Hashemi-Sadraei N, Pennell NA. Advanced non-small cell lung cancer (NSCLC): Maintenance therapy for all? Curr Treat Options Oncol. 2012 Dec;13(4):478-490.

Hashmi M, Karan D, Phadke S, Saunthararajah Y, Kambhampati S, Van Veldhuizen P. Prostate cancer immunotherapy: An evolving field. Curr Cancer Ther Rev. 2012;8(4):274-282.

He H, Osunkoya AO, Carver P, Falzarano S, Klein E, Magi-Galluzzi C, Zhou M. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN. BJU Int. 2012 Dec;110(11 Pt B):E751-E755.

He X, Saji M, Radhakrishnan D, Romigh T, Ngeow J, Yu Q, Wang Y, Ringel MD, Eng C. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome. J Clin Endocrinol Metab. 2012 Nov;97(11):E2179-E2187.

Heald B, Church J, Plesec T, Burke CA. Detecting and managing hereditary colorectal cancer syndromes in your practice. Cleve Clin J Med. 2012 Nov;79(11):787-796.

Heald B, Edelman E, Eng C. Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. Eur J Hum Genet. 2012 May;20(5):547-551.

Heddleston JM, Wu Q, Rivera M, Minhas S, Lathia JD, Sloan AE, Iliopoulos O, Hjelmeland AB, Rich JN. Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential. Cell Death Differ. 2012 Mar;19(3):428-439.

Heindl M, Handel N, Ngeow J, Kionke J, Wittekind C, Kamprad M, Rensing-Ehl A, Ehl S, Reifenberger J, Loddenkemper C, Maul J, Hoffmeister A, Aretz S, Kiess W, Eng C, Uhlig HH. Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome. Gastroenterology. 2012 May;142(5):1093-1096.

Heng DY, Mackenzie MJ, Vaishampayan UN, Bjarnason GA, Knox JJ, Tan MH, Wood L, Wang Y, Kollmannsberger C, North S, Donskov F, Rini BI, Choueiri TK. Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma:

clinical characteristics, risk factors, and subsequent therapy. Ann Oncol. 2012 Jun;23(6):1549-1555.

Henze J, Muhlenberg T, Simon S, Grabellus F, Rubin B, Taeger G, Schuler M, Treckmann J, Debiec-Rychter M, Taguchi T, Fletcher JA, Bauer S. P53 modulation as a therapeutic strategy in gastrointestinal stromal tumors. PLoS One. 2012;7(5):e37776.

Hercbergs AA, Garfield D, Ashur-Fabian O, Davis PJ. Re: thyroid dysfunction from antineoplastic agents. J Natl Cancer Inst. 2012 Mar 7;104(5):422-423.

Herts BR. Renal lymphoma presenting as an incidental renal mass. J Urol. 2012 Jul;188(1):271-273.

Hesson LB, Packham D, Pontzer E, Funchain P, Eng C, Ward RL. A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines. Biol Proced Online. 2012;14(1):5.

Hill BT, Weil AC, Kalaycio M, Cook JR. Pulmonary involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma is a specific pathologic finding independent of inflammatory infiltration. Leuk Lymphoma. 2012 Apr;53(4):589-595.

Hill BT, Sweetenham J. Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma. Leuk Lymphoma. 2012 May;53(5):763-769.

Hjelmeland AB, Rich JN. The quest for self-identity: not all cancer stem cells are the same. Clin Cancer Res. 2012 Jul 1;18(13):3495-3498.

Hobert JA, Mester JL, Moline J, Eng C. Elevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individuals. Genet Med. 2012 Jun;14(6):616-619.

Hobin JA, Deschamps AM, Bockman R, Cohen S, Dechow P, Eng C, Galey W, Morris M, Prabhakar S, Raj U, Rubenstein P, Smith JA, Stover P, Sung N, Talman W, Galbraith R. Engaging basic scientists in translational research: identifying opportunities, overcoming obstacles. J Transl Med. 2012;10:72.

Hopman SMJ, Van Rijn RR, Eng C, Bras J, Alders M, van der Horst CM, Hennekam RCM, Merks JHM. PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon. Am J Med Genet A. 2012 Jul;158A(7):1719-1723.

Hsi ED. Pathologic and molecular genetic features of chronic lymphocytic leukemia. Semin Oncol. 2012 Feb;39(1):74-79.

Hu Z, Saunthararajah Y. CEBPE activation in PML-RARA cells by arsenic. Blood. 2012 Mar 1;119(9):2177-2179.

Huang P, Rani MRS, Ahluwalia MS, Bae E, Prayson RA, Weil RJ, Nowacki AS, Hedayat H, Sloan AE, Lathia JD, Rich JN, Tipps R, Gladson CL. Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin alpha6beta1 in glioblastoma. Cancer Res. 2012 Mar 15;72(6):1428-1437.

Huang TQ, Wang Y, Ebrahem Q, Chen Y, Cheng C, Doughman YQ, Watanabe M, Dunwoodie SL, Yang YC. Deletion of HIF-1alpha partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes. Mol Vis. 2012;18:1260-1270.

Hunter GK, Reddy CA, Klein EA, Kupelian P, Angermeier K, Ulchaker J, Chehade N, Altman A, Ciezki JP. Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer. Prostate Cancer. 2012;2012:853487.

Hunter GK, Suh JH, Reuther AM, Vogelbaum MA, Barnett GH, Angelov L, Weil RJ, Neyman G, Chao ST. Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1394-1398.

Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, Katz A, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria JR. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol. 2012 May;51(5):575-583.

Jagadeesh D, Woda BA, Draper J, Evens AM. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol. 2012 Mar;13(1):122-136.

Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson C, Cahn JY, Cairo M, Gale RP, Gupta V, Lee SJ, Litzow M, Weisdorf DJ, Horowitz MM, Hahn T. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012 Jan 5;119(1):296-307.

Jagasia MH, Abonour R, Long GD, Bolwell BJ, Laport GG, Shore TB, Durrant S, Szer J, Chen MG, Lizambri R, Waller EK. Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplant. 2012 Oct;47(10):1350-1355.

Jarjour NN, Erzurum SC, Bleecker ER, Calhoun WJ, Castro M, Comhair SAA, Chung KF, Curran-Everett D, Dweik RA, Fain SB, Fitzpatrick AM, Gaston BM, Israel E, Hastie A, Hoffman EA, Holguin F, Levy BD, Meyers DA, Moore WC, Peters SP, Sorkness RL, Teague WG, Wenzel SE, Busse WW. Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med. 2012 Feb 15;185(4):356-362.

Jeremic B, Videtic GMM. Induction chemotherapy inevitably leads to inferior outcome in combined modality treatment for unresectable stage III non-small cell lung cancer. J Thorac Oncol. 2012 May;7(5):944-945.

Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Ng KP, Olson T, Przychodzen B, Afable M, Gomez-Segui I, Guinta K, Durkin L, Hsi ED, McGraw K, Zhang D, Wlodarski MW, Porkka K, Sekeres MA, List A, Mustjoki S, Loughran TP, Maciejewski JP. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012 Oct 11;120(15):3048-3057.

Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, Przychodzen B, Visconte V, Tiu RV, O'Keefe CL, Mohamedali AM, Kulasekararaj AG, Pellagatti A, McGraw K, Muramatsu H, Moliterno AR, Sekeres MA, McDevitt MA, Kojima S, List A, Boultwood J, Mufti GJ, Maciejewski JP. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood. 2012 Jun 21;119(25):6109-6117.

Jerez A, Gondek LP, Jankowska AM, Makishima H, Przychodzen B, Tiu RV, O'Keefe CL, Mohamedali AM, Batista D, Sekeres MA, McDevitt MA, Mufti GJ, Maciejewski JP. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. J Clin Oncol. 2012 Apr 20;30(12):1343-1349.

Jin X, Chalmers JJ, Zborowski M. Iron transport in cancer cell culture suspensions measured by cell magnetophoresis. Anal Chem. 2012 May 15;84(10):4520-4526.

Jin X, Abbot S, Zhang X, Kang L, Voskinarian-Berse V, Zhao R, Kameneva MV, Moore LR, Chalmers JJ, Zborowski M. Erythrocyte enrichment in hematopoietic progenitor cell cultures based on magnetic susceptibility of the hemoglobin. PLoS One. 2012;7(8):e39491.

Jonasch E, Futreal PA, Davis IJ, Bailey ST, Kim WY, Brugarolas J, Giaccia AJ, Kurban G, Pause A, Frydman J, Zurita AJ, Rini BI, Sharma P, Atkins MB, Walker CL, Rathmell WK. State of the science: an update on renal cell carcinoma. Mol Cancer Res. 2012 Jul;10(7):859-880.

Joo KM, Jin J, Kim E, Kim KH, Kim Y, Kang BG, Kang YJ, Lathia JD, Cheong KH, Song PH, Kim H, Seol HJ, Kong DS, Lee JI, Rich JN, Lee J, Nam DH. MET signaling regulates glioblastoma stem cells. Cancer Res. 2012 Aug 1;72(15):3828-3838.

Kalady MF, Lipman J, McGannon E, Church JM. Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg. 2012 Jun;255(6):1121-1125.

Kalady MF, DeJulius KL, Sanchez JA, Jarrar A, Liu X, Manilich E, Skacel M, Church JM. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon Rectum. 2012 Feb;55(2):128-133.

Kalady MF, Coffey JC, Dejulius K, Jarrar A, Church JM. High-throughput arrays identify distinct genetic profiles associated with lymph node involvement in rectal cancer. Dis Colon Rectum. 2012 Jun;55(6):628-639.

Kannan S, Staugaitis SM, Weil RJ, Hatipoglu B. A rare corticotroph-secreting tumor with coexisting prolactin and growth hormone staining cells. Case Rep Endocrinol. 2012;2012:529730.

Kantarjian H, Thomas D, Jorgensen J, Jabbour E, Kebriaei P, Rytting M, York S, Ravandi F, Kwari M, Faderl S, Rios MB, Cortes J, Fayad L, Tarnai R, Wang SA, Champlin R, Advani A, O'Brien S. Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study. Lancet Oncol. 2012 Apr;13(4):403-411.

Kawsar HI, Shahnewaz J, Ricaurte B, Daw HA. Barium aspiration. BMJ Case Rep. 2012;2012.

Kawsar HI, Shahnewaz J, Gopalakrishna KV, Spiro TP, Daw HA. Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis. Clin Adv Hematol Oncol. 2012 Jun;10(6):370-378.

Kawsar HI, Shahnewaz J, Bhansali H, Daw H. Rectus sheath haematoma. BMJ Case Rep. 2012;2012.

Kawsar HI, Gopal KV, Shahnewaz J, Daw HA. Constipation in Clostridium difficile infection. BMJ Case Rep. 2012;2012.

Kerr BA, Byzova TV. The dark side of the oxidative force in angiogenesis. Nat Med. 2012 Aug 6;18(8):1184-1185.

Khan MK, Koyfman SA, Hunter GK, Reddy CA, Saxton JP. Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience. Radiat Oncol. 2012 Nov 19;7(1):193.

Khan N, Khan MK, Bena J, Macklis R, Singh AD. Plaque brachytherapy for uveal melanoma: a vision prognostication model. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e285-e290.

Khan SN, Danishuddin M, Varshney B, Lal SK, Khan AU. Inhibition of N-terminal lysines acetylation and transcription factor assembly by epirubicin induced deranged cell homeostasis. PLoS One. 2012;7(12):e51850.

Kibel AS, Ciezki JP, Klein EA, Reddy CA, Lubahn JD, Haslag-Minoff J, Deasy JO, Michalski JM, Kallogjeri D, Piccirillo JF, Rabah DM, Yu C, Kattan MW, Stephenson AJ. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol. 2012 Apr;187(4):1259-1265.

Kim JJ, Vaziri SAJ, Rini BI, Elson P, Garcia JA, Wirka R, Dreicer R, Ganapathi MK, Ganapathi R. Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib. Cancer. 2012 Apr 1;118(7):1946-1954.

Kim Y, Kim E, Wu Q, Guryanova O, Hitomi M, Lathia JD, Serwanski D, Sloan AE, Weil RJ, Lee J, Nishiyama A, Bao S, Hjelmeland AB, Rich JN. Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. Genes Dev. 2012 Jun 1;26(11):1247-1262.

Kiran RP, Kirat HT, Burgess AN, Nisar PJ, Kalady MF, Lavery IC. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy? Ann Surg Oncol. 2012 Apr;19(4):1206-1212.

Kirkova J, Rybicki L, Walsh D, Aktas A. Symptom prevalence in advanced cancer: age, gender, and performance status interactions. Am J Hosp Palliat Care. 2012 Mar;29(2):139-145.

Kisiel-Sajewicz K, Davis MP, Siemionow V, Seyidova-Khoshknabi D, Wyant A, Walsh D, Hou J, Yue GH. Lack of muscle contractile property changes at the time of perceived physical exhaustion suggests central mechanisms contributing to early motor task failure in patients with cancer-related fatigue. J Pain Symptom Manage. 2012 Sep;44(3):351-361.

Klein EA, Thompson IM. Chemoprevention of prostate cancer: an updated view. World J Urol. 2012 Apr;30(2):189-194.

Klein EA. In reply [Prostate cancer risk and vitamin E]. JAMA. 2012 Feb 1;307(5):454.

Klein EA. What is the best way to treat high-risk prostate cancer? Cancer. 2012 Jan 1;118(1):12-14.

Klink JC, Miocinovic R, Magi Galluzzi C, Klein EA. High-grade prostatic intraepithelial neoplasia. Korean J Urol. 2012 May;53(5):297-303.

Komaki R, Paulus R, Ettinger DS, Videtic GMM, Bradley JD, Glisson BS, Langer CJ, Sause WT, Curran WJ, Jr., Choy H. Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e531-e536.

Koroukian SM, Bakaki PM, Raghavan D. Survival disparities by Medicaid status: An analysis of 8 cancers. Cancer. 2012 Sep 1;118(17):4271-4279.

Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmaki H, Andersson EI, Lagstrom S, Clemente MJ, Olson T, Jalkanen SE, Majumder MM, Almusa H, Edgren H, Lepisto M, Mattila P, Guinta K, Koistinen P, Kuittinen T, Penttinen K, Parsons A, Knowles J, Saarela J, Wennerberg K, Kallioniemi O, Porkka K, Loughran TP, Jr., Heckman CA, Maciejewski JP, Mustjoki S. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012 May 17;366(20):1905-1913.

Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, Ghadirian P, Neuhausen SL, Demsky R, Tung N, Ainsworth P, Senter L, Eisen A, Eng C, Singer C, Ginsburg O, Blum J, Huzarski T, Poll A, Sun P, Narod SA. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2012 Mar 9;14(2):R42.

Kotsopoulos J, Lubinski J, Lynch HT, Kim-Sing C, Neuhausen S, Demsky R, Foulkes WD, Ghadirian P, Tung N, Ainsworth P, Senter L, Karlan B, Eisen A, Eng C, Weitzel J, Gilchrist DM, Blum JL, Zakalik D, Singer C, Fallen T, Ginsburg O, Huzarski T, Sun P, Narod SA. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1089-1096.

Koyfman SA, Djemil T, Burdick MJ, Woody N, Balagamwala EH, Reddy CA, Angelov L, Suh JH, Chao ST. Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):297-302.

Koyfman SA, Adelstein DJ. Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: A critical review. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):581-589.

Kshettry VR, Hardy S, Weil RJ, Angelov L, Barnett GH. Immediate titanium cranioplasty after debridement and craniectomy for postcraniotomy surgical site infection. Neurosurgery. 2012 Mar;70(1 Suppl Operative):8-15.

Kulkarni S, Augoff K, Rivera L, McCue B, Khoury T, Groman A, Zhang L, Tian L, Sossey-Alaoui K. Increased expression levels of WAVE3 are associated with the progression and metastasis of Triple Negative Breast Cancer. PLoS One. 2012;7(8):e42895.

Kumagai K, Takeuchi R, Ishikawa H, Yamaguchi Y, Fujisawa T, Kuniya T, Takagawa S, Muschler GF, Saito T. Low-intensity pulsed ultrasound accelerates fracture healing by stimulation of recruitment of both local and circulating osteogenic progenitors. J Orthop Res. 2012 Sep;30(9):1516-1521.

Lamarre ED, Seth R, Lorenz RR, Esclamado R, Adelstein DJ, Rodriguez CP, Saxton J, Scharpf J. Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution. Am J Otolaryngol. 2012 Jan-Feb;33(1):98-103.

Lamarre ED, Batra PS, Lorenz RR, Citardi MJ, Adelstein DJ, Srinivas SM, Scharpf J. Role of positron emission tomography in management of sinonasal neoplasms-a single institution's experience. Am J Otolaryngol. 2012 May-Jun;33(3):289-295.

Landau M, Goldblum JR, Deroche T, Dumot J, Downs-Kelly E, Rice TW, Xiao SY, Liu X. Esophageal carcinoma cuniculatum: report of 9 cases. Am J Surg Pathol. 2012 Jan;36(1):8-17.

Langhauser F, Gob E, Kraft P, Geis C, Schmitt J, Brede M, Gobel K, Helluy X, Pham M, Bendszus M, Jakob P, Stoll G, Meuth SG, Nieswandt B, McCrae KR, Kleinschnitz C. Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation. Blood. 2012 Nov 8;120(19):4082-4092.

Lathia JD, Rich JN. Holding on to stemness. Nat Cell Biol. 2012 May 2;14(5):450-452.

Lathia JD, Li M, Hall PE, Gallagher J, Hale JS, Wu Q, Venere M, Levy E, Rani MRS, Huang P, Bae E, Selfridge J, Cheng L, Guvenc H, McLendon RE, Nakano I, Sloan AE, Phillips HS, Lai A, Gladson CL, Bredel M, Bao S, Hjelmeland AB, Rich JN. Laminin alpha 2 enables glioblastoma stem cell growth. Ann Neurol. 2012 Nov;72(5):766-778.

Lavelle D, Vaitkus K, Ling Y, Ruiz MA, Mahfouz R, Ng KP, Negrotto S, Smith N, Terse P, Engelke KJ, Covey J, Chan KK, DeSimone J, Saunthararajah Y. Effects of

tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine. Blood. 2012 Feb 2;119(5):1240-1247.

Lavelle D, Vaitkus K, Ruiz MA, Ibanez V, Kouznetsova T, Saunthararajah Y, Mahmud N, DeSimone J. Effect of AGM and fetal liver-derived stromal cell lines on globin expression in adult baboon (P. anubis) bone marrow-derived erythroid progenitors. PLoS One. 2012;7(5):e36846.

Lee D, Das Gupta J, Gaughan C, Steffen I, Tang N, Luk KC, Qiu X, Urisman A, Fischer N, Molinaro R, Broz M, Schochetman G, Klein EA, Ganem D, Derisi JL, Simmons G, Hackett J, Jr., Silverman RH, Chiu CY. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer. PLoS One. 2012;7(9):e44954.

LeGrand SB. Delirium in palliative medicine: a review. J Pain Symptom Manage. 2012 Oct;44(4):583-594.

LeGrand SB, Heintz JB. Palliative medicine fellowship: a study of resident choices. J Pain Symptom Manage. 2012 Mar;43(3):558-568.

Lewis CM, Bu D, Sarode V, Robinson L, Wilson KS, Viscusi RK, Eng C, Euhus DM. The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome. Breast Cancer Res Treat. 2012 Dec;136(3):911-918.

Li H, Snow-Lisy D, Klein EA. Hepatic splenosis diagnosed after inappropriate metastatic evaluation in patient with low-risk prostate cancer. Urology. 2012 May;79(5):e73-e74.

Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends Neurosci. 2012 Oct;35(10):619-628.

Li W, Zhang L, Li J. Regenerative medicine for spinal cord injury. Rec Pat Regen Med. 2012;2(3):162-171.

Li X, Ampleford EJ, Howard TD, Moore WC, Torgerson DG, Li H, Busse WW, Castro M, Erzurum SC, Israel E, Nicolae DL, Ober C, Wenzel SE, Hawkins GA, Bleecker ER, Meyers DA. Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol. 2012 Oct;130(4):861-868.

Li X, Ampleford EJ, Howard TD, Moore WC, Li H, Busse WW, Castro M, Erzurum SC, Fitzpatrick AM, Gaston B, Israel E, Jarjour NN, Teague WG, Wenzel SE, Hawkins GA, Bleecker ER, Meyers DA. The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients. J Allergy Clin Immunol. 2012 Feb;129(2):575-578.

Li Y, Komuro Y, Fahrion JK, Hu T, Ohno N, Fenner KB, Wooton J, Raoult E, Galas L, Vaudry D, Komuro H. Light stimuli control neuronal migration by altering of insulin-like growth factor 1 (IGF-1) signaling. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2630-2635.

Li Z, Rice TW. Diagnosis and staging of cancer of the esophagus and esophagogastric junction. Surg Clin North Am. 2012 Oct;92(5):1105-1126.

Lian L, Menon KVN, Shen B, Remzi F, Kiran RP. Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe? Dis Colon Rectum. 2012 Jan;55(1):79-84.

Liang J, Kalady MF, Appau K, Church J. Serrated polyp detection rate during screening colonoscopy. Colorectal Dis. 2012 Nov;14(11):1323-1327.

Lima BR, Singh AD. Bevacizumab therapy for choroidal melanoma. Eur Oncol Haematol. 2012 May;8(2):101-104.

Litzenberg DW, Balter JM, Hadley SW, Hamstra DA, Willoughby TR, Kupelian PA, Djemil T, Mahadevan A, Jani S, Weinstein G, Solberg T, Enke C, Levine L, Sandler HM. Prostate intrafraction translation margins for real-time monitoring and correction strategies. Prostate Cancer. 2012;2012:130579.

Liu H, Johnson JL, Koval G, Malnassy G, Sher D, Damon LE, Hsi ED, Bucci DM, Linker CA, Cheson BD, Stock W. Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909. Haematologica. 2012 Apr;97(4):579-585.

Liu Y, Yu X, Wang L, Li C, Archacki S, Huang C, Liu JY, Wang Q, Liu M, Tang Z. Mutation p.Leu354Pro in EDA causes severe hypohidrotic ectodermal dysplasia in a Chinese family. Gene. 2012 Jan 10;491(2):246-250.

Lotan Y, Goodman PJ, Youssef RF, Svatek RS, Shariat SF, Tangen CM, Thompson IM, Jr., Klein EA. Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. J Urol. 2012 Jun;187(6):2005-2010.

Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Nov 11;44(12):1321-1325.

Lu J, Ksendzovsky A, Yang C, Mehta GU, Yong RL, Weil RJ, Park DM, Mushlin HM, Fang X, Balgley BM, Lee DH, Lee CS, Lonser RR, Zhuang Z. CNTF receptor subunit alpha as a marker for glioma tumor-initiating cells and tumor grade. J Neurosurg. 2012 Dec;117(6):1022-1031.

Lu Q, Yao Y, Yao Y, Liu S, Huang Y, Lu S, Bai Y, Zhou B, Xu Y, Li L, Wang N, Wang L, Zhang J, Cheng X, Qin G, Ma W, Xu C, Tu X, Wang Q. Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model. PLoS One. 2012;7(10):e46998.

Luger SM, Ringden O, Zhang MJ, Perez WS, Bishop MR, Bornhauser M, Bredeson CN, Cairo MS, Copelan EA, Gale RP, Giralt SA, Gulbas Z, Gupta V, Hale GA, Lazarus HM, Lewis VA, Lill MC, McCarthy PL, Weisdorf DJ, Pulsipher MA. Similar outcomes using

myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant. 2012 Feb;47(2):203-211.

Lustberg M, Jatana KR, Zborowski M, Chalmers JJ. Emerging technologies for CTC detection based on depletion of normal cells. Recent Results Cancer Res. 2012;195:97-110.

Luyster FS, Teodorescu M, Bleecker E, Busse W, Calhoun W, Castro M, Chung KF, Erzurum S, Israel E, Strollo PJ, Wenzel SE. Sleep quality and asthma control and quality of life in non-severe and severe asthma. Sleep Breath. 2012 Dec;16(4):1129-1137.

Ma PC. Personalized targeted therapy in advanced non-small cell lung cancer. Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS56-eS60.

Macfarlane R, Heng DYC, Xie W, Knox JJ, McDermott DF, Rini BI, Kollmannsberger C, Choueiri TK. The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy. Cancer. 2012 Jan 15;118(2):365-370.

Maciejewski JP, Haferlach T. Introduction: molecular pathogenesis of hematologic malignancies. Semin Oncol. 2012 Feb;39(1):9-12.

Maciejewski JP, Padgett RA. Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Br J Haematol. 2012 Jul;158(2):165-173.

Macklis R. Finally, a substantial role for radiotherapy in melanoma. Lancet Oncol. 2012 Jun;13(6):561-562.

Mahindra A, Bolwell BJ, Rybicki L, Elder P, Kalaycio M, Dean R, Avalos B, Sobecks R, Tench S, Andresen S, Pohlman B, Sweetenham J, Devine S, Copelan E. Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia. Bone Marrow Transplant. 2012 Feb;47(2):231-235.

Mahindra A, Kalaycio ME, Vela-Ojeda J, Vesole DH, Zhang MJ, Li P, Berenson JR, Bird JM, Dispenzieri A, Gajewski JL, Gale RP, Holmberg L, Kumar S, Kyle RA, Lazarus HM, Lonial S, Mikhael J, Milone GA, Munker R, Nath R, Saccaro S, To LB, Vogl DT, Wirk B, Hari P. Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia. 2012 May;26(5):1091-1097.

Mailloux AW, Sugimori C, Komrokji RS, Yang L, Maciejewski JP, Sekeres MA, Paquette R, Loughran TP, Jr., List AF, Epling-Burnette PK. Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J Immunol. 2012 Sep 15;189(6):3198-3208.

Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu KS, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood. 2012 Apr 5;119(14):3203-3210.

Makishima H, Sugimoto Y, Szpurka H, Clemente MJ, Ng KP, Muramatsu H, O'Keefe C, Saunthararajah Y, Maciejewski JP. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. Leukemia. 2012 Jul;26(7):1547-1554.

Makkar R, Pai RK, Burke CA. Sessile serrated polyps: Cancer risk and appropriate surveillance. Cleve Clin J Med. 2012 Dec;79(12):865-871.

Malinin NL, Pluskota E, Byzova TV. Integrin signaling in vascular function. Curr Opin Hematol. 2012 May;19(3):206-211.

Malinoc A, Sullivan M, Wiech T, Werner SK, Jilg C, Straeter J, Deger S, Hoffmann MM, Bosse A, Rasp G, Eng C, Neumann HPH. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Endocr Relat Cancer. 2012 Jun;19(3):283-290.

Mang T, Bogoni L, Salganicoff M, Wolf M, Raykar V, Macari M, Pickhardt PJ, Iafrate F, Laghi A, Weber M, Baker ME, Ringl H, Herold CJ, Graser A. Computer-aided detection of colorectal polyps in CT colonography with and without fecal tagging: a stand-alone evaluation. Invest Radiol. 2012 Feb;47(2):99-108.

Marcelain K, Armisen R, Aguirre A, Ueki N, Toro J, Colmenares C, Hayman MJ. Chromosomal instability in mouse embryonic fibroblasts null for the transcriptional co-repressor Ski. J Cell Physiol. 2012 Jan;227(1):278-287.

Marko NF, Xu Z, Gao T, Kattan MW, Weil RJ. Predicting survival in women with breast cancer and brain metastasis: A nomogram outperforms current survival prediction models. Cancer. 2012 Aug 1;118(15):3749-3757.

Marko NF, Weil RJ. Comparative effectiveness research in neurosurgery. Neurosurg Focus. 2012 Jul;33(1).

Marko NF, Weil RJ. Response [Comparative effectiveness research and acromegaly]. J Neurosurg. 2012 Sep;117(3):521.

Marko NF, Weil RJ. An introduction to comparative effectiveness research. Neurosurgery. 2012 Feb;70(2):425-434.

Marko NF, Weil RJ. Non-Gaussian distributions affect identification of expression patterns, functional annotation, and prospective classification in human cancer genomes. PLoS One. 2012;7(10):e46935.

Marko NF, Coughlan C, Weil RJ. Towards an integrated molecular and clinical strategy to predict early recurrence in surgically resected non-functional pituitary adenomas. J Clin Neurosci. 2012 Nov;19(11):1535-1540.

Marko NF, Weil RJ. Pituitary gland: New pathways in the pathogenesis of pituitary adenomas. Nat Rev Endocrinol. 2012 Oct;8(10):572-573.

Marko NF, Weil RJ. The molecular biology of WHO grade I astrocytomas. Neuro Oncol. 2012 Dec;14(12):1424-1431.

Marko NF, Prayson RA, Weil RJ. Sellar mass with vision loss and hypopituitarism. J Clin Neurosci. 2012 Sep;19(9):1282,1331.

Marko NF, Weil RJ. The case for a comparative, value-based alternative to the patient-centered outcomes research model for comparative effectiveness research. Neurosurg Focus. 2012 Jul;33(1):E8.

Marko NF, Lasota E, Hamrahian AH, Weil RJ. Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly. J Neurosurg. 2012 Sep;117(3):522-538.

Marotta M, Chen X, Inoshita A, Stephens R, Budd GT, Crowe J, Lyons J, Kondratova A, Tubbs R, Tanaka H. A common copy number breakpoint of ERBB2 amplification in breast cancer co-localizes with a complex block of segmental duplications. Breast Cancer Res. 2012 Nov 26;14(6):R150.

Marwaha G, Wilkinson A, Bena J, Macklis R, Singh AD. Dosimetric benefit of a new ophthalmic radiation plaque. Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1226-1230.

Mazumder S, Choudhary GS, Al-Harbi S, Almasan A. Mcl-1 phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells. Cancer Res. 2012 Jun 15;72(12):3069-3079.

McLennan G, Bennett SL, Ju S, Babsky A, Bansal N, Shorten ML, Levitin S, Bonnac L, Panciewicz KW, Jayaram HN. Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside. Cardiovasc Intervent Radiol. 2012 Jun;35(3):645-652.

McNamara MJ, Adelstein DJ. Current developments in the management of locally advanced esophageal cancer. Curr Oncol Rep. 2012 Aug;14(4):342-349.

Mekhail N, Vallejo R, Coleman MH, Benyamin RM. Long-term results of percutaneous lumbar decompression mild ((R)) for spinal stenosis. Pain Pract. 2012 Mar;12(3):184-193.

Mekhail N. In response to Dr. Tumialan et al [Regarding: Long-term results of percutaneous lumbar decompression mild for spinal stenosis]. Pain Pract. 2012 Mar;12(3):252-253.

Mekhail N, Costandi S, Abraham B, Wadie SS. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012 Jul;12(6):417-425.

Meller J, Malinin NL, Panigrahi S, Kerr BA, Patil A, Ma Y, Venkateswaran L, Rogozin IB, Mohandas N, Ehlayel MS, Podrez EA, Chinen J, Byzova TV. Novel aspects of Kindlin-3 function in humans based on a new case of leukocyte adhesion deficiency III. J Thromb Haemost. 2012 Jul;10(7):1397-1408.

Mendoza R, Silverman RH, Klein EA, Miller AD. No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients. PLoS One. 2012;7(5):e36073.

Messick CA, Church J, Bennett A, Kalady MF. Serrated polyps: new classifications highlight clinical importance. Colorectal Dis. 2012 Nov;14(11):1328-1337.

Messing EM, Albertsen P, Andriole GL, Jr., Carroll PR, Klein EA. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing. Urol Oncol. 2012 Jan-Feb;30(1):117-119.

Mester J, Eng C. Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome. Genet Med. 2012 Sep;14(9):819-822.

Mester JL, Zhou M, Prescott N, Eng C. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology. 2012 May;79(5):1187.

Michal SA, Adelstein DJ, Rybicki LA, Rodriguez CP, Saxton JP, Wood BG, Scharpf J, Ives DI. Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly. Head Neck. 2012 Aug;34(8):1147-1152.

Milas M, Mester J, Metzger R, Shin J, Mitchell J, Berber E, Siperstein AE, Eng C. Should patients with Cowden syndrome undergo prophylactic thyroidectomy? Surgery. 2012 Dec;152(6):1201-1210.

Mitchell JC, Milas M, Berber E, Siperstein A, Shin J, Rice T, Mihaljevic T, Mason D. Thoracic exploration for mediastinal parathyroids requires a multidisciplinary approach. World Journal of Endocrine Surgery. 2012;4(3):87-92.

Mitra AP, Hansel DE, Cote RJ. Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol. 2012 Oct;39(5):524-533.

Mohamad B, Iqbal MN, Gopal KV, Arshad S, Daw HA. Mai infection simulating metastatic breast cancer. BMJ Case Rep. 2012;2012.

Mohammadi AM, Recinos PF, Barnett GH, Weil RJ, Vogelbaum MA, Chao ST, Suh JH, Marko NF, Elson P, Neyman G, Angelov L. Role of Gamma Knife surgery in patients with 5 or more brain metastases. J Neurosurg. 2012 Dec;117 Suppl:5-12.

Morais C, Ebrahem Q, Anand-Apte B, Parat MO. Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase. Am J Pathol. 2012 Apr;180(4):1702-1714.

Mukherjee S, Sekeres MA. What's all the fuss about? Facts and figures about bone marrow failure and conditions. Curr Hematol Malig Rep. 2012 Dec;7(4):300-309.

Mukherjee S, Tiu RV, Sekeres MA. Blood consult: treating del(5q) myelodysplastic syndromes. Blood. 2012 Jan 12;119(2):342-344.

Mulligan GB, Faiman C, Gupta M, Kennedy L, Hatipoglu B, Hui F, Weil RJ, Hamrahian AH. Prolactin measurement during inferior petrosal sinus sampling improves the localization of pituitary adenomas in Cushing's disease. Clin Endocrinol (Oxf ). 2012 Aug;77(2):268-274.

Muramatsu H, Makishima H, Maciejewski JP. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions. Semin Oncol. 2012 Feb;39(1):67-73.

Murphy ES, Merchant TE, Wu S, Xiong X, Lukose R, Wright KD, Qaddoumi I, Armstrong GT, Broniscer A, Gajjar A. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e655-e660.

Nabors LB, Mikkelsen T, Hegi ME, Ye X, Batchelor T, Lesser G, Peereboom D, Rosenfeld MR, Olsen J, Brem S, Fisher JD, Grossman SA. A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306). Cancer. 2012 Nov 15;118(22):5601-5607.

Nademanee AP, DiPersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial. Biol Blood Marrow Transplant. 2012 Oct;18(10):1564-1572.

Naguib M, Xu JJ, Diaz P, Brown DL, Cogdell D, Bie B, Hu J, Craig S, Hittelman WN. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesth Analg. 2012 May;114(5):1104-1120.

Naguib M, Bie B, Ting AH. Fundamental concepts of epigenetics for consideration in anesthesiology. Curr Opin Anaesthesiol. 2012 Aug;25(4):434-443.

Najjar YG, Rini BI. Novel agents in renal carcinoma: a reality check. Ther Adv Med Oncol. 2012 Jul;4(4):183-194.

Neglia E, Singh-Radcliff N, Minzter BH, Kofke WA. Industry support of key opinion leaders. Drug Inf J. 2012 Mar;46(2):180-184.

Negrotto S, Ng KP, Jankowska AM, Bodo J, Gopalan B, Guinta K, Mulloy JC, Hsi E, Maciejewski J, Saunthararajah Y. CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors. Leukemia. 2012 Feb;26(2):244-254.

Neuner EA, Ahrens CL, Groszek JJ, Isada C, Vogelbaum MA, Fissell WH, Bhimraj A. Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult. J Antimicrob Chemother. 2012 Jun;67(6):1558-1560.

Ngeow J, Eng C. PTEN mutations: Help spot thyroid cancer before it occurs. Expert Rev Endocrinol Metab. 2012 May;7(3):251-254.

Ngeow J, He X, Mester JL, Lei J, Romigh T, Orloff MS, Milas M, Eng C. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes. J Clin Endocrinol Metab. 2012 Dec;97(12):E2320-E2327.

Ngeow J, Eng C. Thyroid cancer genetics: How close are we to personalizing clinical management? Per Med. 2012 Jun;9(4):355-358.

Ni Y, Eng C. Vitamin E protects against lipid peroxidation and rescues tumorigenic phenotypes in cowden/cowden-like patient-derived lymphoblast cells with germline SDHx variants. Clin Cancer Res. 2012 Sep 15;18(18):4954-4961.

Ni Y, He X, Chen J, Moline J, Mester J, Orloff MS, Ringel MD, Eng C. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum Mol Genet. 2012 Jan 15;21(2):300-310.

Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene. 2012 Feb 9;31(6):776-786.

Nyland SB, Krissinger DJ, Clemente MJ, Irby RB, Baab KT, Jarbadan NR, Sokol L, Schaefer E, Liao J, Cuthbertson D, Epling-Burnette P, Paquette R, List AF, Maciejewski JP, Loughran TP, Jr. Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: Results of a bone marrow failure consortium study. Leuk Res. 2012 May;36(5):581-587.

O'Brien S, Rizzieri DA, Vey N, Ravandi F, Krug UO, Sekeres MA, Dennis M, Venditti A, Berry DA, Jacobsen TF, Staudacher K, Bergeland T, Giles FJ. Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia. Br J Haematol. 2012 Sep;158(5):581-588.

O'Malley M, LaGuardia L, Kalady MF, Parambil J, Heald B, Eng C, Church J, Burke CA. The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum. 2012 Aug;55(8):886-892.

Obusez EC, Lian L, Kariv R, Burke CA, Shen B. Diagnostic yield of colonoscopy for constipation as the sole indication. Colorectal Dis. 2012 May;14(5):585-591.

Ohshima-Hosoyama S, Davare MA, Prajapati SI, Abraham J, Lal S, Nelon LD, Kilcoyne A, Giles FJ, Hanes MA, Rubin BP, Keller C. Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model. J Pediatr Hematol Oncol. 2012 Mar;34(2):116-121.

Orija IB, Weil RJ, Hamrahian AH. Pituitary incidentaloma. Best Pract Res Clin Endocrinol Metab. 2012 Feb;26(1):47-68.

Orloff MS, Zhang L, Bebek G, Eng C. Integrative genomic analysis reveals extended germline homozygosity with lung cancer risk in the PLCO cohort. PLoS One. 2012;7(2):e31975.

Ornstein MC, Sekeres MA. Combination strategies in myelodysplastic syndromes. Int J Hematol. 2012 Jan;95(1):26-33.

Ostrom QT, McCulloh C, Chen Y, Devine K, Wolinsky Y, Davitkov P, Robbins S, Cherukuri R, Patel A, Gupta R, Cohen M, Vengoechea BJ, Brewer C, Schilero C,

Smolenski K, McGraw M, Denk B, Naska T, Laube F, Steele R, Greene D, Kastl A, Bell S, Aziz D, Chiocca EA, McPherson C, Warnick R, Barnett GH, Sloan AE, Barnholtz-Sloan JS. Family history of cancer in benign brain tumor subtypes versus gliomas. Front Oncol. 2012;2:19.

Oya S, Prayson RA, Lee JH. A tentorial venous hemangioma presenting as an extra-axial mass in the ambient cistern: a case report. J Neurol Surg Rep. 2012 Oct;73(1):37-40.

Paner GP, Aron M, Hansel DE, Amin MB. Non-epithelial neoplasms of the prostate. Histopathology. 2012 Jan;60(1):166-186.

Papadaki ME, Lietman SA, Levine MA, Olsen BR, Kaban LB, Reichenberger EJ. Cherubism: best clinical practice. Orphanet J Rare Dis. 2012 May 24;7 Suppl 1:S6.

Patel M, Vogelbaum MA, Barnett GH, Jalali R, Ahluwalia MS. Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions. Expert Opin Investig Drugs. 2012 Sep;21(9):1247-1266.

Patel SH, Robbins JR, Gore EM, Bradley JD, Gaspar LE, Germano I, Ghafoori P, Henderson MA, Lutz ST, McDermott MW, Patchell RA, Robins HI, Vassil AD, Wippold FJ, Videtic GM. ACR Appropriateness Criteria® follow-up and retreatment of brain metastases. Am J Clin Oncol. 2012 Jun;35(3):302-306.

Patil DT, Goldblum JR, Rybicki L, Plesec TP, Mendelin JE, Bennett AE, Castilla EA, Henricks WH, Schoenfield L, Skacel M, Yerian LM, Rice TW, Bronner MP, Downs-Kelly E. Prediction of adenocarcinoma in esophagectomy specimens based upon analysis of preresection biopsies of barrett esophagus with at least high-grade dysplasia: a comparison of 2 systems. Am J Surg Pathol. 2012 Jan;36(1):134-141.

Patil S, Manola J, Elson P, Negrier S, Escudier B, Eisen T, Atkins M, Bukowski R, Motzer RJ. Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trials. J Urol. 2012 Dec;188(6):2095-2100.

Peereboom DM. Clinical trial design in brain metastasis: approaches for a unique patient population. Curr Oncol Rep. 2012 Feb;14(1):91-96.

Pelayes DE, Zarate JO, Biscotti CV, Singh AD. Calibrated needle for ophthalmic fine needle aspiration biopsy. Br J Ophthalmol. 2012 Aug;96(8):1147-1148.

Pennell NA. Treating ALK-positive lung cancer in the weeks after the FDA approval of crizotinib. Am J Manag Care. 2012 May;18(2 Spec No.):SP84-SP87.

Pennell NA. Treating anaplastic lymphoma kinase-positive lung cancer in the weeks after the US Food and Drug Administration approval of crizotinib. J Oncol Pract. 2012 May;8(3 Suppl):34s-37s.

Pennell NA, Yin L, Keshtgarpour M, Ma PC. Two generations of light/never-smokers with advanced adenocarcinoma of the lung with durable responses to erlotinib. J Thorac Oncol. 2012 Jul;7(7):1200-1201.

Pennell NA. Selection of chemotherapy for patients with advanced non-small cell lung cancer. Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS46-eS50.

Petrosyan F, Daw H, Haddad A, Spiro T. Targeted therapy for lung cancer. Anticancer Drugs. 2012 Nov;23(10):1016-1021.

Petty A, Myshkin E, Qin H, Guo H, Miao H, Tochtrop GP, Hsieh JT, Page P, Liu L, Lindner DJ, Acharya C, Mackerell AD, Jr., Ficker E, Song J, Wang B. A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo. PLoS One. 2012;7(8):e42120.

Philips S, Shah SN, Vikram R, Verma S, Shanbhogue AKP, Prasad SR. Pancreatic endocrine neoplasms: a current update on genetics and imaging. Br J Radiol. 2012 Jun;85(1014):682-696.

Pietanza MC, Lynch TJ, Jr., Lara PN, Jr., Cho J, Yanagihara RH, Vrindavanam N, Chowhan NM, Gadgeel SM, Pennell NA, Funke R, Mitchell B, Wakelee HA, Miller VA. XL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib. J Thorac Oncol. 2012 Jan;7(1):219-226.

Platzbecker U, Santini V, Mufti GJ, Haferlach C, Maciejewski JP, Park S, Sole F, van de Loosdrecht AA, Haase D. Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): Consensus statements and report from an expert workshop. Leuk Res. 2012 Mar;36(3):264-270.

Portell CA, Sweetenham JW. Adult lymphoblastic lymphoma. Cancer J. 2012 Sep-Oct;18(5):432-438.

Portell CA, Advani AS. Antibody therapy for acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2012 Jun;7(2):153-159.

Portell CA, Sekeres MA, Rogers HJ, Tiu RV. De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone. Br J Haematol. 2012 Apr;157(2):266-267.

Prithviraj GK, Koroukian S, Margevicius S, Berger NA, Bagai R, Owusu C. Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012 Jul 1;3(3):228-237.

Purysko AS, Herts BR. Prostate MRI: The hemorrhage exclusion sign. J Urol. 2012 Nov;188(5):1946-1947.

Purysko AS, Leao Filho HM, Herts BR. Radiologic imaging of patients with bladder cancer. Semin Oncol. 2012 Oct;39(5):543-558.

Qiu J, Tsien C, Thapalaya S, Narayanan A, Weihl CC, Ching JK, Eghtesad B, Singh K, Fu X, Dubyak G, McDonald C, Almasan A, Hazen SL, Naga Prasad SV, Dasarathy S. Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis. Am J Physiol Endocrinol Metab. 2012 Oct;303(8):E983-E993.

Quintini C, Ward G, Shatnawei A, Xhaja X, Hashimoto K, Steiger E, Hammel J, Diago Uso T, Burke CA, Church JM. Mortality of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis: a single center review of 154 patients. Ann Surg. 2012 Mar;255(3):511-516.

Radivoyevitch T, Saunthararajah Y, Pink J, Ferris G, Lent I, Jackson M, Junk D, Kunos CA. dNTP supply gene expression patterns after P53 loss. Cancers (Basel). 2012 Nov 20;4(4):1212-1224.

Rahmathulla G, Toms SA, Weil RJ. The molecular biology of brain metastasis. J Oncol. 2012;2012:723541.

Rahmathulla G, Recinos PF, Valerio JE, Chao S, Barnett GH. Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg. 2012;90(3):192-200.

Rahmathulla G, Recinos PF, Traul DE, Avitsian R, Yunak M, Harper NT, Barnett GH, Recinos VR. Surgical briefings, checklists, and the creation of an environment of safety in the neurosurgical intraoperative magnetic resonance imaging suite. Neurosurg Focus. 2012 Nov;33(5):E12.

Ratajczak J, Kucia M, Mierzejewska K, Liu R, Kim CH, Natarajan N, Sharma V, Miller DM, Maciejewski J, Ratajczak MZ. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient. Leukemia. 2012 Jul;26(7):1722-1725.

Raza A, Galili N, Smith SE, Godwin J, Boccia RV, Myint H, Mahadevan D, Mulford D, Rarick M, Brown GL, Schaar D, Faderl S, Komrokji RS, List AF, Sekeres M. A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome. Cancer. 2012 Apr 15;118(8):2138-2147.

Raza A, Galili N, Mulford D, Smith SE, Brown G, Steensma DP, Lyons RM, Boccia R, Sekeres MA, Guillermo GM, Mesa RA. Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS). J Hematol Oncol. 2012 Apr 30;5(1):18.

Reardon DA, Vredenburgh JJ, Desjardins A, Peters KB, Sathornsumetee S, Threatt S, Sampson JH, Herndon JE, II, Coan A, McSherry F, Rich JN, McLendon RE, Zhang S, Friedman HS. Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma. J Neurooncol. 2012 Jul;108(3):499-506.

Reardon DA, Herndon JE, II, Peters KB, Desjardins A, Coan A, Lou E, Sumrall AL, Turner S, Lipp ES, Sathornsumetee S, Rich JN, Sampson JH, Friedman AH, Boulton ST, Bigner DD, Friedman HS, Vredenburgh JJ. Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients. Br J Cancer. 2012 Oct 23;107(9):1481-1487.

Reardon DA, Wen PY, Alfred Yung WK, Berk L, Narasimhan N, Turner CD, Clackson T, Rivera VM, Vogelbaum MA. Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial. Cancer Chemother Pharmacol. 2012 Apr;69(4):849-860.

Reardon DA, Desjardins A, Vredenburgh JJ, Herndon JE, Coan A, Gururangan S, Peters KB, McLendon R, Sathornsumetee S, Rich JN, Lipp ES, Janney D, Friedman HS. Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. Cancer. 2012 Oct 1;118(19):4759-4767.

Reardon DA, Cloughesy T, Rich J, Yung WKA, Yung L, DiLea C, Huang J, Dugan M, Mietlowski W, Maes A, Conrad C. Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma. Cancer Chemother Pharmacol. 2012 Jan;69(1):281-287.

Reardon DA, Herndon JE, II, Peters K, Desjardins A, Coan A, Lou E, Sumrall A, Turner S, Sathornsumetee S, Rich JN, Boulton S, Lipp ES, Friedman HS, Vredenburgh JJ. Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients. J Neurooncol. 2012 Mar;107(1):213-221.

Rehman S, Reddy CA, Tendulkar RD. Modern outcomes of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):619-624.

Reichenberger EJ, Levine MA, Olsen BR, Papadaki ME, Lietman SA. The role of SH3BP2 in the pathophysiology of cherubism. Orphanet J Rare Dis. 2012 May 24;7 Suppl 1:S5.

Reikvam H, Tiu RV. Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera. Leukemia. 2012 Apr;26(4):563-571.

Revenaugh PC, Knott PD, Scharpf J, Fritz MA. Simultaneous anterolateral thigh flap and temporalis tendon transfer to optimize facial form and function after radical parotidectomy. Arch Facial Plast Surg. 2012 Mar-Apr;14(2):104-109.

Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, O'Brien MJ, Odze RD, Ogino S, Parry S, Snover DC, Torlakovic EE, Wise PE, Young J, Church J. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012 Sep;107(9):1315-1329.

Rice TW, Goldblum JR. Management of Barrett esophagus with high-grade dysplasia. Thorac Surg Clin. 2012 Feb;22(1):101-107.

Rice TW, Blackstone EH. Biologic prosthesis and laparoscopic paraesophageal hernia repair: "It ain't over till it's over". J Am Coll Surg. 2012 Jul;215(1):157-158.

Rice TW, Blackstone EH. Minimally invasive versus open esophagectomy for cancer: more questions than answers. Ann Surg. 2012 Feb;255(2):204-205.

Rini B. Dissecting responsive phenotypes through cytokine and angiogenic factor analysis. Ann Oncol. 2012 Jan;23(1):6-7.

Rini B, Szczylik C, Tannir NM, Koralewski P, Tomczak P, Deptala A, Dirix LY, Fishman M, Ramlau R, Ravaud A, Rogowski W, Kracht K, Sun YN, Bass MB, Puhlmann M, Escudier B. AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney : A randomized, double-blind, placebo-controlled, phase 2 study. Cancer. 2012 Dec 15;118(24):6152-6161.

Rini BI, Garcia J, Elson P, Wood L, Shah S, Stephenson A, Salem M, Gong M, Fergany A, Rabets J, Kaouk J, Krishnamurthi V, Klein E, Dreicer R, Campbell S. The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery. J Urol. 2012 May;187(5):1548-1554.

Rizk MK, Tolba R, Kapural L, Mitchell J, Lopez R, Mahboobi R, Vrooman B, Mekhail N. Differential epidural block predicts the success of visceral block in patients with chronic visceral abdominal pain. Pain Pract. 2012 Nov;12(8):595-601.

Robinson B, Magi-Galluzzi C, Zhou M. Intraductal carcinoma of the prostate. Arch Pathol Lab Med. 2012 Apr;136(4):418-425.

Robles Irizarry L, Hambardzumyan D, Nakano I, Gladson CL, Ahluwalia MS. Therapeutic targeting of VEGF in the treatment of glioblastoma. Expert Opin Ther Targets. 2012 Sep;16(10):973-984.

Rodrigues G, Louie A, Videtic G, Best L, Patil N, Hallock A, Gaede S, Kempe J, Battista J, De Haan P, Bauman G. Categorizing segmentation quality using a quantitative quality assurance algorithm. J Med Imaging Radiat Oncol. 2012 Dec;56(6):668-678.

Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Scharpf J, Ives DI. Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck. Head Neck. 2012 Nov;34(11):1517-1523.

Roobol MJ, Schroder FH, Hugosson J, Jones JS, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Vickers AJ, Lilja H, Steyerberg EW. Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. World J Urol. 2012 Apr;30(2):149-155.

Sade B, Batra PS, Scharpf J, Citardi MJ, Lee JH. Minimally invasive endoscopic endonasal management of skull base cholesterol granulomas. World Neurosurg. 2012 Dec;78(6):683-688.

Sadeghi S, Garcia JA. Current status of targeted therapy in metastatic transitional cell carcinoma of the bladder. Semin Oncol. 2012 Oct;39(5):608-614.

Sadeghi S, Albiges L, Wood LS, Black SL, Gilligan TD, Dreicer R, Garcia JA, Escudier BJ, Rini BI. Cessation of vascular endothelial growth factor-targeted therapy in patients with metastatic renal cell carcinoma: Feasibility and clinical outcome. Cancer. 2012 Jul 1;118(13):3277-3282.

Sahgal A, Ma L, Weinberg V, Gibbs IC, Chao S, Chang UK, Werner-Wasik M, Angelov L, Chang EL, Sohn MJ, Soltys SG, Letourneau D, Ryu S, Gerszten PC, Fowler J, Wong CS, Larson DA. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):107-116.

Saito Y, Aoki Y, Muramatsu H, Makishima H, Maciejewski JP, Imaizumi M, Rikiishi T, Sasahara Y, Kure S, Niihori T, Tsuchiya S, Kojima S, Matsubara Y. Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia. Leuk Res. 2012 Aug;36(8):1009-1015.

Sakaguchi H, Makishima H, Muramatsu H, Visconte V, Jerez A, Jankowska AM, Tiu RV, Maciejewski JP, Kojima S. Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies. Leuk Res. 2012 Dec;36(12):e215-e217.

Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MR. Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol. 2012 Mar 10;30(8):830-836.

Samala RV, Davis MP. Palliative care per rectum #257. J Palliat Med. 2012 Sep;15(9):1038-1039.

Sanyal R, Lall CG, Lamba R, Verma S, Shah SN, Tirkes T, Berry WA, Sandrasegaran K. Orthotopic liver transplantation: Reversible Doppler US findings in the immediate postoperative period. Radiographics. 2012 Jan-Feb;32(1):199-211.

Sathornsumetee S, Rich JN. Molecularly targeted therapy in neuro-oncology. Handb Clin Neurol. 2012;104:255-278.

Saunthararajah Y, Maciejewski J. Polycomb segment myeloid malignancies. Blood. 2012 Feb 2;119(5):1097-1098.

Saunthararajah Y, Triozzi P, Rini B, Singh A, Radivoyevitch T, Sekeres M, Advani A, Tiu R, Reu F, Kalaycio M, Copelan E, Hsi E, Lichtin A, Bolwell B. p53-independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies. Semin Oncol. 2012 Feb;39(1):97-108.

Sava MR, Rubin B, Sundaram M. Subpubic cyst. Skeletal Radiol. 2012 Jul;41(7):867-868.

Sava MR, Rubin B, Sundaram M. Subpubic cyst. Subpubic degenerative cyst arising from the fibrocartilage of the pubic symphysis. Skeletal Radiol. 2012 Jul;41(7):851-858.

Scheppke L, Murphy EA, Zarpellon A, Hofmann JJ, Merkulova A, Shields DJ, Weis SM, Byzova TV, Ruggeri ZM, Iruela-Arispe ML, Cheresh DA. Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood. 2012 Mar 1;119(9):2149-2158.

Schonberg DL, Bao S, Rich JN. TRP-ing up brain tumors. Nat Med. 2012 Aug 6;18(8):1175-1176.

Schuessler A, Funk A, Lazear HM, Cooper DA, Torres S, Daffis S, Jha BK, Kumagai Y, Takeuchi O, Hertzog P, Silverman R, Akira S, Barton DJ, Diamond MS, Khromykh AA. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. J Virol. 2012 May;86(10):5708-5718.

Schwandt A, Mekhail T, Halmos B, O'Brien T, Ma PC, Fu P, Ivy P, Dowlati A. Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer. J Thorac Oncol. 2012 Apr;7(4):751-754.

Schwele S, Fischer AM, Brestrich G, Wlodarski MW, Wagner L, Schmueck M, Roemhild A, Thomas S, Hammer MH, Babel N, Kurtz A, Maciejewski JP, Reinke P, Volk HD. Cytomegalovirus-specific regulatory and effector T cells share TCR clonality--possible relation to repetitive CMV infections. Am J Transplant. 2012 Mar;12(3):669-681.

Scott JG, Bauchet L, Fraum TJ, Nayak L, Cooper AR, Chao ST, Suh JH, Vogelbaum MA, Peereboom DM, Zouaoui S, Mathieu-Daude H, Fabbro-Peray P, Rigau V, Taillandier L, Abrey LE, Deangelis LM, Shih JH, Iwamoto FM. Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer. 2012 Nov 15;118(22):5595-5600.

Seicean A, Schiltz NK, Seicean S, Alan N, Neuhauser D, Weil RJ. Use and utility of preoperative hemostatic screening and patient history in adult neurosurgical patients. J Neurosurg. 2012 May;116(5):1097-1105.

Seicean S, Seicean A, Plana JC, Budd GT, Marwick TH. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: An observational clinical cohort study. J Am Coll Cardiol. 2012 Dec 11;60(23):2384-2390.

Sekeres MA. My AML cytogenetics classification scheme is better than yours. Biol Blood Marrow Transplant. 2012 Feb;18(2):160-161.

Sekeres MA. How to manage lower-risk myelodysplastic syndromes. Leukemia. 2012 Mar;26(3):390-394.

Sekeres MA, Tiu RV, Komrokji R, Lancet J, Advani AS, Afable M, Englehaupt R, Juersivich J, Cuthbertson D, Paleveda J, Tabarroki A, Visconte V, Makishima H, Jerez A, Paquette R, List AF, Maciejewski JP. Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes. Blood. 2012 Dec 13;120(25):4945-4951.

Sekeres MA. Myelodysplastic syndromes: it is all in the genes. J Clin Oncol. 2012 Mar 10;30(8):774-776.

Sekeres MA, Steensma DP. Boulevard of broken dreams: drug approval for older adults with acute myeloid leukemia. J Clin Oncol. 2012 Nov 20;30(33):4061-4063.

Sekeres MA. Very superstitious. J Clin Oncol. 2012 Aug 20;30(24):3026-3027.

Sella A, Hercbergs AH, Hanovich E, Kovel S. Does sunitinib-induced hypothyroidism play a role in the activity of sunitinib in metastatic renal cell carcinoma? Chemotherapy. 2012 Jun 29;58(3):200-205.

Seregard S, Singh AD. Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity. Br J Ophthalmol. 2012 Apr;96(4):473-474.

Shah L, Samala RV, Davis MP. Posterior reversible encephalopathy syndrome: an unexpected finding in a palliative care unit. J Pain Symptom Manage. 2012 Jul;44(1):e3-e6.

Shantha Kumara HMC, Kirchoff D, Naffouje S, Grieco M, Herath SAC, Dujovny N, Kalady MF, Hyman N, Njoh L, Whelan RL. Plasma from the second and third weeks after open colorectal resection for cancer stimulates in vitro endothelial cell growth, migration, and invasion. Surg Endosc. 2012 Mar;26(3):790-795.

Shantha Kumara HMC, Tohme ST, Herath SAC, Yan X, Senagore AJ, Nasar A, Kalady MF, Baxter R, Whelan RL. Plasma soluble vascular adhesion molecule-1 levels are persistently elevated during the first month after colorectal cancer resection. Surg Endosc. 2012 Jun;26(6):1759-1764.

Shapiro M. The role of adjuvant chemotherapy in early-stage and locally advanced non-small cell lung cancer. Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS42-eS45.

Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: A marker for DNA damage. Methods Mol Biol. 2012;920:613-626.

Shen GQ, Li L, Wang QK. Genetic variant R952Q in LRP8 is associated with increased plasma triglyceride levels in patients with early-onset CAD and MI. Ann Hum Genet. 2012 May;76(3):193-199.

Shepard DR, Cooney MM, Elson P, Bukowski RM, Dreicer R, Rini BI, Garcia JA. A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma. Invest New Drugs. 2012 Feb;30(1):364-367.

Sheplan Olsen LJ, Robles Irizarry L, Chao ST, Weil RJ, Hamrahian AH, Hatipoglu B, Suh JH. Radiotherapy for prolactin-secreting pituitary tumors. Pituitary. 2012 Jun;15(2):135-145.

Shoemaker LK, Aktas A, Walsh D, Hullihen B, Khan MIA, Russell KM, Davis MP, Lagman R, LeGrand S. A pilot study of palliative medicine fellows' hospice home visits. Am J Hosp Palliat Care. 2012 Dec;29(8):591-598.

Siegel DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi F, Reu FJ, Somlo G, Zonder J, Song K, Stewart AK, Stadtmauer E, Kunkel L, Wear S, Wong AF, Orlowski RZ, Jagannath S. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. Blood. 2012 Oct 4;120(14):2817-2825.

Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, Reed K, Narouze S, Mogilner A, Goldstein J, Trentman T, Vaisma J, Ordia J, Weber P, Deer T, Levy R, Diaz RL, Washburn SN, Mekhail N. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012 Dec;32(16):1165-1179.

Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Nephrometry score is associated with volume loss and functional recovery after partial nephrectomy. J Urol. 2012 Jul;188(1):39-44.

Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury. J Urol. 2012 May;187(5):1667-1673.

Simmons MN, Campbell SC. Editorial comment [Intraoperative mannitol use does not improve long-term renal function outcomes after minimally invasive partial nephrectomy]. Urology. 2012 Apr;79(4):825-826.

Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Diameter-axial-polar nephrometry: integration and optimization of R.e.N.a.L. And centrality index scoring systems. J Urol. 2012 Aug;188(2):384-390.

Singh AD, Pelayes DE, Brainard JA, Biscotti CV. History, indications, techniques and limitations. Monogr Clin Cytol. 2012;21:1-9.

Singh AD, Dolan B, Biscotti CV. Future of ophthalmic fine needle aspiration biopsy. Monogr Clin Cytol. 2012;21:90-96.

Singh AD, Biscotti CV. Fine needle aspiration biopsy of ophthalmic tumors. Saudi J Ophthalmol. 2012 Apr;26(2):117-123.

Singh AD, Pabon S, Aronow ME. Management of radiation maculopathy. Ophthalmic Res. 2012;48 Suppl 1:26-31.

Singh AD, Aronow ME, Sun Y, Bebek G, Saunthararajah Y, Schoenfield LR, Biscotti CV, Tubbs RR, Triozzi PL, Eng C. Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array. Invest Ophthalmol Vis Sci. 2012;53(7):3331-3339.

Singh K, Matsuyama S, Drazba JA, Almasan A. Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy. 2012 Feb 1;8(2):236-251.

Sinnott M, Falzarano SM, Hernandez AV, Jones JS, Klein EA, Zhou M, Magi-Galluzzi C. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy. Prostate. 2012 Aug 1;72(11):1179-1186.

Smith AD, Remer EM, Cox KL, Lieber ML, Allen BC, Shah SN, Herts BR. Bosniak category IIF and III cystic renal lesions: Outcomes and associations. Radiology. 2012 Jan;262(1):152-160.

Sobecks RM, Rybicki L, Yurch M, Kalaycio M, Dean R, Andresen S, Pohlman B, Duong H, Bolwell B, Copelan E. Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS. Bone Marrow Transplant. 2012 May;47(5):633-638.

Sohal DPS, Sun W. Preoperative treatment of locally advanced rectal cancer. Eur Oncol Haematol. 2012 Nov;8(4):224-227.

Sonpavde G, Choueiri TK, Escudier B, Ficarra V, Hutson TE, Mulders PF, Patard JJ, Rini BI, Staehler M, Sternberg CN, Stief CG. Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy? Eur Urol. 2012 Feb;61(2):307-316.

Sood R, Daw HA. Pleomorphic malignant histiocytoma: a rare skin cancer in a patient on azathioprine for ulcerative colitis. BMJ Case Rep. 2012;2012.

Soriano MA, Lagman R. When the patient says no. Am J Hosp Palliat Care. 2012 Aug;29(5):401-404.

Sourianarayanane A, El-Gazzaz G, Sanabria JR, Menon KVN, Quintini C, Hashimoto K, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F. Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. HPB (Oxford). 2012 May;14(5):325-332.

Sourianarayanane A, Aucejo F, Miller C, Lopez R, Zein NN, McCullough AJ, Menon KVN. Liver transplantation for hepatocellular carcinoma among African Americans in the United States. International Journal of Organ Transplantation Medicine. 2012 Apr;3(2):85-91.

Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JPS, Sperduto CM, Lin N, Mehta M. Reply to M.C. Chamberlain et al [Is graded prognostic assessment an improvement compared with radiation therapy oncology group's recursive partitioning analysis classification for brain metastases?]. J Clin Oncol. 2012 Sep 10;30(26):3316-3317.

Sperduto PW, Sneed PK, Roberge D, Shanley R, Luo X, Luo X, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Knisely JPS, Lin N, Mehta M. In regard to Yamamoto et al [Subclassification of recursive partitioning analysis class II patients with brain metastases treated radiosurgically]. Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):875-876.

Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JPS, Sperduto CM, Lin N, Mehta M. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2111-2117.

Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JPS, Sperduto CM, Lin N, Mehta M. Summary report on the

graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012 Feb 1;30(4):419-425.

Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, McLaughlin VV, Jessup M, Grizzle WE, Aldred MA, Cool CD, Tuder RM. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012 Aug 1;186(3):261-272.

Stacy RC, Jakobiec FA, Herwig MC, Schoenfield L, Singh A, Grossniklaus HE. Diffuse large B-cell lymphoma of the orbit: clinicopathologic, immunohistochemical, and prognostic features of 20 cases. Am J Ophthalmol. 2012 Jul;154(1):87-98.

Stephans K. Stereotactic body radiotherapy for stage I non-small cell lung cancer. Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS26-eS31.

Stephans KL, Djemil T, Tendulkar RD, Robinson CG, Reddy CA, Videtic GMM. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT). Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):974-980.

Stephenson AJ, Bolla M, Briganti A, Cozzarini C, Moul JW, Roach M, III, van Poppel H, Zietman A. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol. 2012 Mar;61(3):443-451.

Stockham AL, Tievsky AL, Koyfman SA, Reddy CA, Suh JH, Vogelbaum MA, Barnett GH, Chao ST. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol. 2012 Aug;109(1):149-158.

Stockham AL, Suh JH, Chao ST, Barnett GH. Management of recurrent brain metastasis after radiosurgery. Prog Neurol Surg. 2012;25:273-286.

Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012 Sep;48(14):2192-2202.

Suarez C, Rini BI. Determining the optimal dose and schedule of sunitinib: some answers, more questions. Cancer. 2012 Mar 1;118(5):1178-1180.

Subbarayan SK, Fleseriu M, Gordon MB, Brzana JA, Kennedy L, Faiman C, Hatipoglu BA, Prayson RA, Delashaw JB, Weil RJ, Hamrahian AH. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone. Endocr Pract. 2012 Nov-Dec;18(6):817-825.

Sugimori C, Padron E, Caceres G, Shain K, Sokol L, Zhang L, Tiu R, O'Keefe CL, Afable M, Clemente M, Lee JM, Maciejewski JP, List AF, Epling-Burnette PK, Araten DJ. Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J. 2012 Mar;2(3):e63.

Sugimoto Y, Sekeres MA, Makishima H, Traina F, Visconte V, Jankowska A, Jerez A, Szpurka H, O'Keefe CL, Guinta K, Afable M, Tiu R, McGraw KL, List AF, Maciejewski J. Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. J Hematol Oncol. 2012;5(1):4.

Sun D, Elson P, Liedtke M, Medeiros BC, Earl M, Alizadeh A, Bates J, Sekeres MA, Coutre S, Kalaycio M, Sobecks R, Copelan E, Advani AS. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia. Am J Hematol. 2012 Oct;87(10):957-960.

Swanson KE, Bartholomew JR, Paulson R. Hypothenar hammer syndrome: A case and brief review. Vasc Med. 2012 Apr;17(2):108-115.

Szefler SJ, Wenzel S, Brown R, Erzurum SC, Fahy JV, Hamilton RG, Hunt JF, Kita H, Liu AH, Panettieri RA, Jr., Schleimer RP, Minnicozzi M. Asthma outcomes: Biomarkers. J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S9-S23.

Tabarroki A, Tiu RV. Immunomodulatory agents in myelofibrosis. Expert Opin Investig Drugs. 2012 Aug;21(8):1141-1154.

Tan A, Kim R, El-Gazzaz G, Menon N, Aucejo F. Serum vascular endothelial growth factor level in patients with hepatocellular carcinoma undergoing liver transplantation: Experience of a single western center. International Journal of Organ Transplantation Medicine. 2012;3(1):41-51.

Tan M, Burden-Gulley SM, Li W, Wu X, Lindner D, Brady-Kalnay SM, Gulani V, Lu ZR. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model. Pharm Res. 2012 Apr;29(4):953-960.

Tan MH, De S, Bebek G, Orloff MS, Wesolowski R, Downs-Kelly E, Budd GT, Stark GR, Eng C. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer. Breast Cancer Res Treat. 2012 Feb;131(3):849-858.

Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012 Jan 15;18(2):400-407.

Tan MH, Mester J, Eng C. Lifetime cancer risks of PTEN mutation carriers - Response. Clin Cancer Res. 2012 Aug 1;18(15):4214.

Tendulkar RD, Rehman S, Shukla ME, Reddy CA, Moore H, Budd GT, Dietz J, Crowe JP, Macklis R. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e577-e581.

Tendulkar RD, Reddy CA, Stephans KL, Ciezki JP, Klein EA, Mahadevan A, Kupelian PA. Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1397-1404.

Teng K, Eng C, Hess CA, Holt MA, Moran RT, Sharp RR, Traboulsi EI. Building an innovative model for personalized healthcare. Cleve Clin J Med. 2012 Apr;79 Suppl 1:S1-S9.

Teng KA, Eng C. Personalizing patient care. Cleve Clin J Med. 2012 May;79(5):329-330.

Thakkar VV, Chao ST, Barnett GH, LeGrand S, Rasmussen P, Vogelbaum MA, Reddy CA, Jamison B, Suh J. Quality of life after gamma knife radiosurgery for benign lesions: a prospective study. Journal of Radiosurgery and SBRT. 2012;1(4):281-286.

Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012 Feb;79(2):356-360.

Thota S, Kistangari G, Daw H, Spiro T. Immune thrombocytopenia in adults: An update. Cleve Clin J Med. 2012 Sep;79(9):641-650.

Timur AA, Murugesan G, Zhang L, Aung PP, Barnard J, Wang QK, Gaussem P, Silverstein RL, Bhatt DL, Kottke-Marchant K. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol. 2012 Oct;34(5):473-483.

Tiu R, Kalaycio M. Targeted therapy for patients with chronic myeloid leukemia: clinical trial experience and challenges in inter-trial comparisons. Leuk Lymphoma. 2012 Jul;53(7):1263-1272.

Tomblyn M, Chen M, Kukreja M, Aljurf MD, Al Mohareb F, Bolwell BJ, Cahn JY, Carabasi MH, Gale RP, Gress RE, Gupta V, Hale GA, Ljungman P, Maziarz RT, Storek J, Wingard JR, Young JAH, Horowitz MM, Ballen KK. No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation. Transpl Infect Dis. 2012 Oct;14(5):468-478.

Tomek IM, Sabel AL, Froimson MI, Muschler G, Jevsevar DS, Koenig KM, Lewallen DG, Naessens JM, Savitz LA, Westrich JL, Weeks WB, Weinstein JN. A collaborative of leading health systems finds wide variations in total knee replacement delivery and takes steps to improve value. Health Aff (Millwood). 2012 Jun;31(6):1329-1338.

Torgerson DG, Capurso D, Ampleford EJ, Li X, Moore WC, Gignoux CR, Hu D, Eng C, Mathias RA, Busse WW, Castro M, Erzurum SC, Fitzpatrick AM, Gaston B, Israel E, Jarjour NN, Teague WG, Wenzel SE, Rodriguez-Santana JR, Rodriguez-Cintron W, Avila PC, Ford JG, Barnes KC, Burchard EG, Howard TD, Bleecker ER, Meyers DA, Cox NJ, Ober C, Nicolae DL. Genome-wide ancestry association testing identifies a common European variant on 6q14.1 as a risk factor for asthma in African American subjects. J Allergy Clin Immunol. 2012 Sep;130(3):622-629.

Torre-Healy A, Marko NF, Weil RJ. Hyperosmolar therapy for intracranial hypertension. Neurocrit Care. 2012 Aug;17(1):117-130.

Traina F, Visconte V, Jankowska AM, Makishima H, O'Keefe CL, Elson P, Han Y, Hsieh FH, Sekeres MA, Mali RS, Kalaycio M, Lichtin AE, Advani AS, Duong HK, Copelan E, Kapur R, Olalla Saad ST, Maciejewski JP, Tiu RV. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PLoS One. 2012;7(8):e43090.

Triozzi PL, Singh AD. Blood biomarkers for uveal melanoma. Future Oncol. 2012 Feb;8(2):205-215.

Triozzi PL, Achberger S, Aldrich W, Singh AD, Grane R, Borden EC. The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon. J Transl Med. 2012 Dec 5;10(1):241.

Triozzi PL, Aldrich W, Achberger S, Ponnazhagan S, Alcazar O, Saunthararajah Y. Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice. Cancer Immunol Immunother. 2012 Sep;61(9):1441-1450.

Triozzi PL, Achberger S, Aldrich W, Elson P, Garcia J, Dreicer R. Differential immunologic and microRNA effects of 2 dosing regimens of recombinant human granulocyte/macrophage colony stimulating factor. J Immunother. 2012 Sep;35(7):587-594.

Trock BJ, Brotzman MJ, Mangold LA, Bigley JW, Epstein JI, Mcleod D, Klein EA, Jones JS, Wang S, Mcaskill T, Mehrotra J, Raghavan B, Partin AW. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies. BJU Int. 2012 Jul;110(1):56-62.

Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Gaspar LE, Sperduto PW, Vogelbaum MA, Radawski JD, Wang JZ, Gillin MT, Mohideen N, Hahn CA, Chang EL. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2012 Jul;2(3):210-225.

Turell ME, Tubbs RR, Biscotti CV, Singh AD. Uveal melanoma: prognostication. Monogr Clin Cytol. 2012;21:55-60.

Tuupanen S, Yan J, Turunen M, Gylfe AE, Kaasinen E, Li L, Eng C, Culver DA, Kalady MF, Pennison MJ, Pasche B, Manne U, de la Chapelle A, Hampel H, Henderson BE, Le Marchand L, Hautaniemi S, Askhtorab H, Smoot D, Sandler RS, Keku T, Kupfer SS, Ellis NA, Haiman CA, Taipale J, Aaltonen LA. Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583. Cancer Genet. 2012 Jan-Feb;205(1-2):25-33.

Tyler A. Urothelial cancers: ureter, renal pelvis, and bladder. Semin Oncol Nurs. 2012 Aug;28(3):154-162.

Udoji E, Herts BR. Renal cell carcinoma metastatic to the ovary. J Urol. 2012 Aug;188(2):603-604.

Ulatowski L, Dreussi C, Noy N, Barnholtz-Sloan J, Klein E, Manor D. Expression of the alpha-tocopherol transfer protein gene is regulated by oxidative stress and common single-nucleotide polymorphisms. Free Radic Biol Med. 2012 Oct 16;53(12):2318-2326.

Unnikrishnan R, Herts BR, Sabanegh E. Symptomatic mullerian duct cyst. J Urol. 2012 Sep;188(3):963-964.

Vatolin S, Khan SN, Reu FJ. Direct chromatin PCR (DC-PCR): hypotonic conditions allow differentiation of chromatin states during thermal cycling. PLoS One. 2012;7(9):e44690.

Vaziri SAJ, Tavares EJ, Golshayan AR, Rini BI, Aydin H, Zhou M, Sercia L, Wood L, Ganapathi MK, Bukowski RM, Ganapathi R. Differing von Hippel Lindau genotype in paired primary and metastatic tumors in patients with clear cell renal cell carcinoma. Front Oncol. 2012;2:51.

Videtic GMM. Locally advanced non-small cell lung cancer: What is the optimal concurrent chemoradiation regimen? Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS32-eS37.

Videtic GMM. The development of stereotactic body radiotherapy (SBRT) for medically inoperable early stage non-small cell lung cancer: an international phenomenon. J Radiat Oncol. 2012 Mar;1(1):3-10.

Vij R, Wang M, Kaufman JL, Lonial S, Jakubowiak AJ, Stewart AK, Kukreti V, Jagannath S, McDonagh KT, Alsina M, Bahlis NJ, Reu FJ, Gabrail NY, Belch A, Matous JV, Lee P, Rosen P, Sebag M, Vesole DH, Kunkel LA, Wear SM, Wong AF, Orlowski RZ, Siegel DS. An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma. Blood. 2012 Jun 14;119(24):5661-5670.

Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ESG, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WWL, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJM, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia. 2012 Sep;26(9):2103-2113.

Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A, O'Keefe C, Rogers HJ, Sekeres MA, Maciejewski JP, Tiu RV. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia. 2012 Mar;26(3):542-545.

Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood. 2012 Oct 18;120(16):3173-3186.

Visconte V, Makishima H, Maciejewski JP, Tiu RV. Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders. Leukemia. 2012 Dec;26(12):2447-2454.

Vogelbaum MA, Iannotti CA. Convection-enhanced delivery of therapeutic agents into the brain. Handb Clin Neurol. 2012;104:355-362.

Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Macdonald DR, van den Bent MJ, Chang SM. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery. 2012 Jan;70(1):234-243.

von Mehren M, Rankin C, Goldblum JR, Demetri GD, Bramwell V, Ryan CW, Borden E. Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas. Cancer. 2012 Feb 1;118(3):770-776.

Wahdan-Alaswad RS, Bane KL, Song K, Shola DTN, Garcia JA, Danielpour D. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin. Mol Cancer Res. 2012 Jun;10(6):821-833.

Wang-Gillam A, Arnold SM, Bukowski RM, Rothenberg ML, Cooper W, Wang KK, Gauthier E, Lockhart AC. A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors. Invest New Drugs. 2012 Feb;30(1):266-272.

Wang J, Sullenger BA, Rich JN. Notch signaling in cancer stem cells. Adv Exp Med Biol. 2012;727:174-185.

Wang WL, Evans HL, Meis JM, Liegl-Atzwanger B, Bovee JV, Goldblum JR, Billings SD, Rubin BP, Lopez-Terrada D, Lazar AJ. FUS rearrangements are rare in 'pure' sclerosing epithelioid fibrosarcoma. Mod Pathol. 2012 Jun;25(6):846-853.

Wang X, Tian H, Lee Z, Heston WDW. Structure-activity relationships of 2',5'-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists. Nucleosides Nucleotides Nucleic Acids. 2012 May;31(5):432-444.

Wang Y, He X, Ngeow J, Eng C. GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer. Hum Mol Genet. 2012 Feb 1;21(3):569-576.

Wang Y, Abu-Asab MS, Li W, Aronow ME, Singh AD, Chan CC. Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy. BMC Ophthalmol. 2012;12:56.

Warrier SK, Kalady MF. Familial adenomatous polyposis: Challenges and pitfalls of surgical treatment. Clin Colon Rectal Surg. 2012 Jun;25(2):83-89.

Wartak SA, Bartholomew JR. In reply [Dabigatran]. Cleve Clin J Med. 2012 Mar;79(3):168-169.

Waterman J, Rybicki L, Bolwell B, Copelan E, Pohlman B, Sweetenham J, Dean R, Sobecks R, Andresen S, Kalaycio M. Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2012 Apr;47(4):488-493.

Watts KE, Montironi R, Mazzucchelli R, Van Der Kwast T, Osunkoya AO, Stephenson AJ, Hansel DE. Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma. Urology. 2012 Aug;80(2):361-366.

Weber C, Kasberg H, Copelan E. Successful hematopoietic stem cell transplantation following a cyclophosphamide-containing preparative regimen with concomitant phenobarbital administration. Case Rep Transplant. 2012;2012:721857.

Weber DM, Graef T, Hussein M, Sobecks RM, Schiller GJ, Lupinacci L, Hardwick JS, Jagannath S. Phase I trial of vorinostat combined with bortezomib for the treatment of relapsing and/or refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):319-324.

Wei L, Warburton RR, Preston IR, Roberts KE, Comhair SAA, Erzurum SC, Hill NS, Fanburg BL. Serotonylated fibronectin is elevated in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2012 Jun;302(12):L1273-L1279.

Weissman SM, Burt R, Church J, Erdman S, Hampel H, Holter S, Jasperson K, Kalady MF, Haidle JL, Lynch HT, Palaniappan S, Wise PE, Senter L. Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. J Genet Couns. 2012 Aug;21(4):484-493.

Wendtner CM, Hillmen P, Mahadevan D, Buhler A, Uharek L, Coutre S, Frankfurt O, Bloor A, Bosch F, Furman RR, Kimby E, Gribben JG, Gobbi M, Dreisbach L, Hurd DD, Sekeres MA, Ferrajoli A, Shah S, Zhang J, Moutouh-de PL, Hallek M, Heerema NA, Stilgenbauer S, Chanan-Khan AA. Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia. Leuk Lymphoma. 2012 Mar;53(3):417-423.

West XZ, Meller N, Malinin NL, Deshmukh L, Meller J, Mahabeleshwar GH, Weber ME, Kerr BA, Vinogradova O, Byzova TV. Integrin beta(3) crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch. PLoS One. 2012;7(2):e31071.

Will B, Zhou L, Vogler TO, Ben-Neriah S, Schinke C, Tamari R, Yu Y, Bhagat TD, Bhattacharyya S, Barreyro L, Heuck C, Mo Y, Parekh S, McMahon C, Pellagatti A, Boultwood J, Montagna C, Silverman L, Maciejewski J, Greally JM, Ye BH, List AF, Steidl C, Steidl U, Verma A. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. Blood. 2012 Sep 6;120(10):2076-2086.

Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED. A

Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica. 2012 May;97(5):758-765.

Wood LS, Zhou M. Pathology of genitourinary malignancies: implications for clinical management. Semin Oncol Nurs. 2012 Aug;28(3):143-153.

Wood LS, Gornell S, Rini BI. Maximizing clinical outcomes with axitinib therapy in advanced renal cell carcinoma through proactive side-effect management. Community Oncol. 2012 Feb;9(2):46-55.

Wood LS. Introduction [Genitourinary malignancies]. Semin Oncol Nurs. 2012 Aug;28(3):141-142.

Woody NM, Videtic GMM, Stephans KL, Djemil T, Kim Y, Xia P. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):427-434.

Wu X, Burden-Gulley SM, Yu GP, Tan M, Lindner D, Brady-Kalnay SM, Lu ZR. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer. Bioconjug Chem. 2012 Aug 15;23(8):1548-1556.

Xia P, Qi P, Rembert J, Hu AZ, Quivey JM, Yom SS. A treatment planning method to avoid the larynx and eliminate the match-line in the treatment of head and neck cancer with intensity-modulated radiation therapy. J Radiat Oncol. 2012 Jun;1(2):187-194.

Xie H, Peereboom DM. Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma. J Clin Oncol. 2012 Jul 20;30(21):e192-e194.

Xu-Monette ZY, Wu L, Visco C, Tai YC, Tzankov A, Liu WM, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Zhao XF, Choi WWL, Zhao X, van Krieken JH, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJM, Zhou F, Kahl BS, Winter JN, Xu W, Li J, Go RS, Li Y, Piris MA, Moller MB, Miranda RN, Abruzzo LV, Medeiros LJ, Young KH. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 2012 Nov 8;120(19):3986-3996.

Xu DS, Yang C, Proescholdt M, Brundl E, Brawanski A, Fang X, Lee CS, Weil RJ, Zhuang Z, Lonser RR. Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival. PLoS One. 2012;7(5):e37811.

Xu J, Mahajan K, Xue W, Winter JO, Zborowski M, Chalmers JJ. Simultaneous, single particle, magnetization and size measurements of micron sized, magnetic particles. J Magn Magn Mater. 2012 Dec 1;324(24):4189-4199.

Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, Vessella RL, Montironi R, Magi-Galluzzi C, Kantoff PW, Balk SP, Liu XS, Brown M. EZH2 oncogenic activity in castration-

resistant prostate cancer cells is Polycomb-independent. Science. 2012 Dec 14;338(6113):1465-1469.

Xu Y, Hu B, Choi AJ, Gopalan B, Lee BH, Kalady MF, Church JM, Ting AH. Unique DNA methylome profiles in CpG island methylator phenotype colon cancers. Genome Res. 2012 Feb;22(2):283-291.

Xu Z, Marko NF, Angelov L, Barnett GH, Chao ST, Vogelbaum MA, Suh JH, Weil RJ. Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer. Cancer. 2012 Mar 1;118(5):1323-1333.

Xu Z, Marko NF, Chao ST, Angelov L, Vogelbaum MA, Suh JH, Barnett GH, Weil RJ. Relationship between HER2 status and prognosis in women with brain metastases from breast cancer. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e739-e747.

Yang C, Iyer RR, Yu ACH, Yong RL, Park DM, Weil RJ, Ikejiri B, Brady RO, Lonser RR, Zhuang Z. beta-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas. Proc Natl Acad Sci U S A. 2012 May 1;109(18):6963-6968.

Yaskiv O, Rubin BP, He H, Falzarano S, Magi-Galluzzi C, Zhou M. ERG protein expression in human tumors detected with a rabbit monoclonal antibody. Am J Clin Pathol. 2012 Dec;138(6):803-810.

Zaytoun OM, Stephenson AJ, Fareed K, El-Shafei A, Gao T, Levy D, Jones JS. When serial prostate biopsy is recommended: most cancers detected are clinically insignificant. BJU Int. 2012 Oct;110(7):987-992.

Zeng W, Fu K, Quintanilla-Fend L, Lim M, Ondrejka S, Hsi ED. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol. 2012 Feb;36(2):214-219.

Zhang A, Sun Y, Viny A, Thomas D, Askar M. Description of two new MICA alleles: MICA*058 and MICA*002:03. Tissue Antigens. 2012 Feb;79(2):144-145.

Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Miezcowski P, Dunphy CH, Choi WWL, Auv WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Gordon LI, Czader MB, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima DD, Luftig M, Ni T, Jun Z, Chadburn A, Levy S, Dunson DB, Dave SS. The genetic landscape of immune-competent and HIV lymphoma. Infect Agent Cancer. 2012;7(Suppl 1):1-2.

Zhang JM, Wang P, Yao JX, Zhao L, Davis MP, Walsh D, Yue GH. Music interventions for psychological and physical outcomes in cancer: a systematic review and meta-analysis. Support Care Cancer. 2012 Dec;20(12):3043-3053.

Zhang K, Wong P, Zhang L, Jacobs B, Borden EC, Aster JC, Bedogni B. A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth. Oncogene. 2012 Oct 25;31(43):4609-4618.

Zhang L, Liu R, Wang Z, Culver DA, Wu R. Modeling haplotype-haplotype interactions in case-control genetic association studies. Front Genet. 2012;3:2.

Zhang X, Gibson B, Jr., Mori R, Snow-Lisy D, Yamaguchi Y, Campbell SC, Simmons MN, Daly TM. Analytical and biological validation of a multiplex immunoassay for acute kidney injury biomarkers. Clin Chim Acta. 2012 Oct 2;415C:88-93.

Zhang Z, Lee JC, Lin L, Olivas V, Au V, Laframboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nat Genet. 2012 Aug;44(8):852-860.

Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, Silverman RH, Weiss SR. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe. 2012 Jun 14;11(6):607-616.

Zhao Y, Malinin NL, Meller J, Ma Y, West XZ, Bledzka K, Qin J, Podrez EA, Byzova TV. Regulation of cell adhesion and migration by kindlin-3 cleavage by calpain. J Biol Chem. 2012 Nov 16;287(47):40012-40020.

Zhou D, Spain J, Moon E, McLennan G, Sands MJ, Wang W. Retrospective review of 120 celect inferior vena cava filter retrievals: experience at a single institution. J Vasc Interv Radiol. 2012 Dec;23(12):1557-1563.

Books, Whole Biscotti CV, Singh AD. FNA Cytology of Ophthalmic Tumors. Basel ; New York, NY: Karger; 2012. 99 pgs.

Figlin RA, Rathmell WK, Rini BI. Renal Cell Carcinoma : Translational Biology, Personalized Medicine, and Novel Therapeutic Targets. New York, NY: Springer; 2012. 327 pgs.

Hansel DE, McKenney JK, Stephenson AJ, Chang SS. The Urinary Tract : a Comprehensive Guide to Patient Diagnosis and Management. New York, NY: Springer; 2012. 354 pgs.

Hsi ED. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier/Saunders; 2012. 744 pgs.

Longnecker DE, Brown DL, Newman MF, Zapol WM. Anesthesiology. 2nd ed. New York , NY: McGraw-Hill Medical; 2012. 1748 pgs.

Raghavan D, Blanke CD, Johnson DH, Moots PL, Reaman GH, Rose PG, Sekeres MA. Textbook of Uncommon Cancer. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2012. 991 pgs.

Singh AD, Hayden BC. Ophthalmic Ultrasonography . Edinburgh: Elsevier/Saunders; 2012. 215 pgs.

van Zundert J, Patijn J, Hartrick CT, Lataster A, Huygen FJPM, Mekhail N, van Kleef M. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. 216 pgs.

Book Chapters Abouassaly R, Thompson IM, Jr., Platz EA, Klein EA. Epidemiology, etiology, and prevention of prostate cancer. In: Wein AJ, ed. Campbell-Walsh Urology. 10th ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 95. p. 2704-2725.

Abouassaly R, Thompson IM, Jr., Platz EA, Klein EA. Epidemiology, etiology, and prevention of prostate cancer. In: McDougal WS, ed. Campbell-Walsh Urology Tenth Edition Review. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 95. p. 498-502.

Ahluwalia MS. Chemotherapy for brain tumors. In: Quinones-Hinojosa A, ed. Schmidek and Sweet Operative Neurosurgical Techniques : Indications, Methods, and Results. 6th ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 7. p. 94-104.

Ali K, Zhou M, Campbell S, Bukowski R, Rini BI. Uncommon tumors of the kidney. In: Raghavan D, ed. Textbook of Uncommon Cancer. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2012. Chapter 1. p. 1-22.

Ariss MM, Traboulsi EI, Singh AD. Systemic associations of eyelid tumors. In: Traboulsi EI, ed. Genetic Diseases of the Eye. 2nd ed. New York, NY: Oxford University Press; 2012. Chapter 47. p. 807-815.

Bartholomew JR. Perioperative management of anticoagulation in the patient with the antiphosholipid syndrome in cardiac surgery and cardiac interventions. In: Mandell BF, ed. Perioperative Management of Patients With Rheumatic Disease. New York, NY: Springer; 2012. Chapter 9. p. 109-127.

Bilsky MH, Angelov L. Stereotaxic radiosurgery for spine tumors. In: Benzel EC, ed. The Cervical Spine. 5th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012. Chapter 59. p. 809-819.

Broaddus E, Patno D, Reid J, Chapa J, Traboulsi EI, Singh AD. Prenatal imaging of the eye and ocular adnexae. In: Traboulsi EI, ed. Genetic Diseases of the Eye. 2nd ed. New York, NY: Oxford University Press; 2012. Chapter 11. p. 163-173.

Campbell SC, Lane BR. Malignant renal tumors. In: McDougal WS, ed. Campbell-Walsh Urology Tenth Edition Review. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 49. p. 270-280.

Campbell SC, Lane BR. Malignant renal tumors. In: Wein AJ, ed. Campbell-Walsh Urology. 10th ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 49. p. 1413-1474.

Choueiri M, Singh AD. Ophthalmic cancers. In: Raghavan D, ed. Textbook of Uncommon Cancer. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2012. Chapter 62. p. 835-846.

Cohen B, Klein EA. Controversies and opportunities for PSA screening. In: Shoskes DA, ed. Urological Men's Health : a Guide for Urologists and Primary Care Physicians. New York, NY: Humana Press; 2012. Chapter 3. p. 23-28.

Cornelissen P, van Kleef M, Mekhail N, Day M, van Zundert J. Persistent idiopathic facial pain. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 3. p. 14-17.

deGroot PG, Raschi E, McCrae KR, Pierangeli SS, Vlachoyiannopoulos PG, Urbanus RT. What are the target cells and receptors that are recognized by antiphospholipid antibodies? In: Erkan D, Pierangeli SS, eds. Antiphospholipid Syndrome : Insights and Highlights From the 13th International Congress on Antiphospholipid Antibodies. New York, NY: Springer; 2012. Chapter 6. p. 103-113.

Devulder J, van Suijlekom H, van Dongen R, Diwan S, Mekhail N, van Kleef M, Huygen F. Ischemic pain in the extremities and Raynaud's phenomenon. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 25. p. 196-201.

Edelman E, Belfort RN, Fu EX, Singh AD. Genetics of retinoblastoma. In: Traboulsi EI, ed. Genetic Diseases of the Eye. 2nd ed. New York, NY: Oxford University Press; 2012. Chapter 49. p. 828-841.

Flechner SM, Finke JH, Fairchild RL. Basic principles of immunology in urology. In: Wein AJ, ed. Campbell-Walsh Urology. 10th ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 17. p. 495-529.

Flechner SM, Finke JH, Fairchild RL. Basic principles of immunology in urology. In: McDougal WS, ed. Campbell-Walsh Urology Tenth Edition Review. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 17. p. 86-90.

Garcia JA, Shepard DR, Dreicer R. Urothelial carcinoma: Role of perioperative systemic chemotherapy. In: Hansel DE, McKenney JK, Stephenson AJ, Chang SS, eds. The Urinary Tract : a Comprehensive Guide to Patient Diagnosis and Management. New York, NY: Springer; 2012. Chapter 15. p. 283-292.

Ginat DT, Moonis G, Hayden BC, Singh AD. Imaging the postoperative orbit. In: Ginat DT, Westesson PLA, eds. Atlas of Postsurgical Neuroradiology : Imaging of the Brain, Spine, Head, and Neck. Heidelberg: Springer; 2012. Chapter 2. p. 33-73.

Hansel DE, Fergany A. Squamous cell carcinoma. In: Hansel DE, McKenney JK, Stephenson AJ, Chang SS, eds. The Urinary Tract : a Comprehensive Guide to Patient Diagnosis and Management. New York, NY: Springer; 2012. Chapter 10. p. 183-193.

Harel R, Angelov L. Metastatic tumors of the spine. In: Ghogawala Z, ed. The Evidence for Neurosurgery. Harley, Shrewsbury: tfm Pub; 2012. Chapter 10. p. 113-128.

Hayden BC, Singh AD. Clinical methods: A- and B- scans. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 3. p. 9-23.

Hayden BC, Kelley L, Singh AD. Theoretical considerations. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 1. p. 1-4.

Hayden BC, Singh AD. Practical considerations. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 2. p. 5-7.

Hayden BC, Singh AD. Clinical methods: Ultrasound biomicroscopy. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 4. p. 25-29.

Horwitz LJ. Perioperative management of the neutropenic rheumatologic patient. In: Mandell BF, ed. Perioperative Management of Patients With Rheumatic Disease. New York, NY: Springer; 2012. Chapter 12. p. 155-163.

Hsi ED. B-cell leukemias of mature lymphocytes. In: Hsi ED, ed. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 12. p. 387-402.

Huygen F, Patijn J, Rohof O, Lataster A, Mekhail N, van Kleef M, van Zundert J. Painful shoulder complaints. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 9. p. 55-61.

Joyce DM, Joyce MJ. Total hip arthroplasty in rheumatic disease and associated inflammatory arthropathies. In: Mandell BF, ed. Perioperative Management of Patients With Rheumatic Disease. New York, NY: Springer; 2012. Chapter 31. p. 327-340.

Joyce DM, Joyce MJ. Total knee arthroplasty in rheumatoid disease and other associated inflammatory arthropathies. In: Mandell BF, ed. Perioperative Management of Patients With Rheumatic Disease. New York, NY: Springer; 2012. Chapter 32. p. 341-352.

Kalady MF, Lavery IC. Parastomal hernia. In: Fazio VW, Church JM, Wu JS, eds. Atlas of Intestinal Stomas. New York, NY: Springer; 2012. Chapter 20. p. 237-243.

Kallewaard JW, Terheggen MAMB, Groen GJ, Sluijter ME, Derby R, Kapural L, Mekhail N, van Kleef M. Discogenic low back pain. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 15. p. 107-122.

Klink JC, Stephenson AJ, McKenney JK. Micropapillary carcinoma. In: Hansel DE, McKenney JK, Stephenson AJ, Chang SS, eds. The Urinary Tract : a Comprehensive Guide to Patient Diagnosis and Management. New York, NY: Springer; 2012. Chapter 8. p. 165-172.

Lathia JD, Li M, Bonnamain V, Rich JN. Stem cell pathways in brain tumors. In: Rao MS, Carpenter M, Vemuri MC, eds. Neural Development and Stem Cells. 3rd ed. New York, NY: Springer; 2012. Chapter 13. p. 329-349.

Lazaryan A, Sweetenham J. Rare T cell lymphomas. In: Raghavan D, ed. Textbook of Uncommon Cancer. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2012. Chapter 48. p. 659-666.

Lo SS, Sloan AE, Machtay M, Teh BS, Sahgal A, Chao ST, Chang EL. Spinal metastasis. In: Lo SS, ed. Stereotactic Body Radiation Therapy. New York, NY: Springer; 2012. p. 355-371.

Lorenz RR, Couch ME, Burkey BB. Head and neck. In: Townsend CM, Jr., ed. Sabiston Textbook of Surgery : the Biological Basis of Modern Surgical Practice. 19th ed. Philadelphia, PA: Elsevier Saunders; 2012. Chapter 35. p. 793-822.

Lystad LD, Hayden BC, Singh AD. Optic nerve diseases. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 13. p. 149-160.

Marko NF, Weil RJ. Brain tumor: Pituitary. In: Lynn DJ, Newton HB, Rae-Grant AD, eds. The 5-Minute Neurology Consult. 2nd ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2012. p. 104-105.

McHaffie DR, Khuntia D, Suh JH, Tome W, Mehta MP. Stereotactic irradiation: Linear accelerator and gamma knife. In: Gunderson LL, Tepper JE, eds. Clinical Radiation Oncology. 3rd ed. Philadelphia, PA: Saunders/Elsevier; 2012. Chapter 17. p. 331-343.

Murphy ES, Merchant TE. Low-grade glioma in children: Effects of radiotherapy. In: Hayat MA, ed. Pediatric Cancer : Diagnosis, Therapy, and Prognosis. Dordrecht: Springer; 2012. Chapter 23. p. 211-217.

O'Malley DP, Hsi ED. Non-neoplastic morphologic abnormalities of white blood cells and macrophages. In: Hsi ED, ed. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 3. p. 99-110.

Patijn J, Vallejo R, Janssen M, Huygen F, Lataster A, van Kleef M, Mekhail N. Carpal tunnel syndrome. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 19. p. 151-154.

Patijn J, Mekhail N, Hayek S, Lataster A, van Kleef M, van Zundert J. Meralgia paresthetica. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 20. p. 155-159.

Patijn J, Janssen M, Hayek S, Mekhail N, van Zundert J, van Kleef M. Coccygodynia. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 14. p. 103-106.

Pluijms W, Huygen F, Cheng J, Mekhail N, van Kleef M, van Zundert J, van Dongen R. Painful diabetic polyneuropathy. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 18. p. 145-150.

Pope JE, Mekhail N. Minimally invasive procedures for vertebral compression fractures. In: Farag E, ed. Anesthesia for Spine Surgery. Cambridge: Cambridge University Press; 2012. Chapter 8.6. p. 141-152.

Puylaert M, Kapural L, van Zundert J, Peek D, Lataster A, Mekhail N, van Kleef M, Keulemans YCA. Pain in chronic pancreatitis. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 26. p. 202-211.

Rahmathulla G, Park JJ, Barnett GH. Craniopharyngiomas. In: Raghavan D, ed. Textbook of Uncommon Cancer. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2012. Chapter 61. p. 823-834.

Rice TW. Surgery for cancer of the esophagus and gastroesophageal junction. In: Richter JE, Castell DO, eds. The Esophagus. 5th ed. Chichester, West Sussex: Wiley-Blackwell; 2012. Chapter 35. p. 637-668.

Rice TW. The new seventh edition AJCC/UICC esophageal cancer staging system. In: Franco KL, Thourani VH, eds. Cardiothoracic Surgery Review. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012. Chapter 311. p. 1365-1368.

Rockwood EJ, Hayden BC, Singh AD. Glaucoma. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 9. p. 87-96.

Rosenquist RW, Brown DL. Incorporating regional anesthesia into anesthetic practice. In: Longnecker DE, Brown DL, Newman MF, Zapol WM, eds. Anesthesiology. 2nd ed. New York , NY: McGraw-Hill Medical; 2012. Chapter 46. p. 783-785.

Sachdeva R, Broaddus E, Singh AD. Ocular prenatal imaging. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 14. p. 161-170.

Sadeghi S, Rini B. Angiogenesis inhibitor therapy in renal cell cancer. In: Lara PN, Jonasch E, eds. Kidney Cancer : Principles and Practice. Heidelberg ; New York, NY: Springer-Verlag; 2012. Chapter 13. p. 197-207.

Santhiago MR, Dupps WJ, Jr., Singh AD. Corneal diseases. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 8. p. 77-85.

Shin JH, Angelov L. Stereotactic radiosurgery for the treatment of spinal metastases. In: Benzel EC, ed. Spine Surgery : Techniques, Complication Avoidance, and Management. 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 176. p. 1671-1680.

Singh AD, Agarwal A. Neoplastic diseases of the choroid. In: Agarwal A, ed. Gass' Atlas of Macular Diseases. 5th ed. Edinburgh: Elsevier Saunders; 2012. Chapter 14. p. 1179-1253.

Singh AD, Agarwal A. Neoplastic diseases of the retina. In: Agarwal A, ed. Gass' Atlas of Macular Diseases. 5th ed. Edinburgh: Elsevier Saunders; 2012. Chapter 13. p. 1099-1178.

Singh AD, Agarwal A. Tumors of the retinal pigment epithelium (RPE). In: Agarwal A, ed. Gass' Atlas of Macular Diseases. 5th ed. Edinburgh: Elsevier Saunders; 2012. Chapter 12. p. 1065-1097.

Singh AD, Schachat AP. Treatment of retinal capillary angioma. In: Spaeth GL, ed. Ophthalmic Surgery : Principles and Practice. 4th ed. Edinburgh: Elsevier; 2012. p. 622-623.

Slack GW, Hsi ED, Gascoyne RD. Diffuse aggressive B-cell lymphomas. In: Hsi ED, ed. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 8. p. 261-292.

Stephenson AJ. Treatment of localized prostate cancer. In: Shoskes DA, ed. Urological Men's Health : a Guide for Urologists and Primary Care Physicians. New York, NY: Humana Press; 2012. Chapter 14. p. 141-154.

Stephenson AJ, Gilligan TD. Neoplasms of the testis. In: McDougal WS, ed. Campbell-Walsh Urology Tenth Edition Review. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 31. p. 150-159.

Stephenson AJ, Gilligan TD. Neoplasms of the testis. In: Wein AJ, ed. Campbell-Walsh Urology. 10th ed. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 31. p. 837-870.

Stofko DL, Weil RJ, Toms SA. Surgery for brain metastasis. In: Palmieri D, ed. Central Nervous System Metastasis, the Biological Basis and Clinical Considerations. Dordrecht ; New York, NY: Springer Science + Business Media; 2012. Chapter 7. p. 109-132.

Suarez C, Rini BI. Targeting the VEGF pathway in renal cell carcinoma. In: Figlin RA, Rathmell WK, Rini BI, eds. Renal Cell Carcinoma : Translational Biology, Personalized Medicine, and Novel Therapeutic Targets. New York, NY: Springer; 2012. Chapter 6. p. 115-133.

Suh JH, Chao ST, Weil RJ. Pituitary tumors. In: Gunderson LL, Tepper JE, eds. Clinical Radiation Oncology. 3rd ed. Philadelphia, PA: Saunders/Elsevier; 2012. Chapter 27. p. 493-509.

Taylor JM, Bochner B, Amin MB, Hansel DE. Muscle-invasive urothelial carcinoma: Conventional and variant subtypes. In: Hansel DE, McKenney JK, Stephenson AJ, Chang SS, eds. The Urinary Tract : a Comprehensive Guide to Patient Diagnosis and Management. New York, NY: Springer; 2012. Chapter 7. p. 143-163.

Traboulsi EI, Singh AD. Pediatric eye diseases. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 15. p. 171-177.

Turell ME, Singh AD. Nonvascular hamartomas. In: Wright KW, Strube YNJ, eds. Pediatric Ophthalmology and Strabismus. 3rd ed. New York, NY: Oxford University Press; 2012. Chapter 48. p. 928-937.

Turell ME, Hayden BC, Schoenfield L, Singh AD. Intraocular tumors. In: Singh AD, Hayden BC, eds. Ophthalmic Ultrasonography. Edinburgh: Elsevier/Saunders; 2012. Chapter 11. p. 111-131.

Van Calster B, Cheng J, Patijn J, van Kleef M, Lataster A, Mekhail N, van Zundert J. Lumbosacral radicular pain. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 11. p. 71-86.

van Dongen R, Cohen SP, van Kleef M, Mekhail N, Huygen F. Traumatic plexus lesion. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 22. p. 168-172.

Van Eerd M, Patijn J, Lataster A, Rosenquist RW, van Kleef M, Mekhail N, van Zundert J. Cervical facet pain. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 5. p. 31-39.

van Eijs F, Stanton-Hicks M, van Zundert J, Faber CG, Lubenow TR, Mekhail N, van Kleef M, Huygen F. Complex regional pain syndrome. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 16. p. 123-136.

van Kleef M, Staats P, Mekhail N, Huygen F. Chronic refractory angina. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 24. p. 191-195.

van Kleef M, Stolker RJ, Lataster A, Geurts JW, Benzon HT, Mekhail N. Thoracic pain. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 10. p. 62-70.

van Kleef M, Vanelderen P, Cohen SP, Lataster A, van Zundert J, Mekhail N. Pain originating from the lumbar facet joints. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 12. p. 87-95.

van Kleef M, Van Genderen WE, Narouze S, Nurmikko TJ, van Zundert J, Geurts JW, Mekhail N. Trigeminal neuralgia. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 1. p. 1-7.

van Kleef M, Lataster A, Narouze S, Mekhail N, Geurts JW, van Zundert J. Cluster headache. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 2. p. 8-13.

van Suijlekom H, van Zundert J, Narouze S, van Kleef M, Mekhail N. Cervicogenic headache. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 6. p. 40-44.

van Suijlekom H, Mekhail N, Patel N, van Zundert J, van Kleef M, Patijn J. Whiplash-associated disorders. In: van Zundert J, ed. Evidence-Based Interventional Pain

Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 7. p. 45-48.

Van Wijck AJM, Wallace M, Mekhail N, van Kleef M. Herpes zoster and poet-herpetic neuralgia. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 17. p. 137-144.

van Zundert J, Vanelderen P, Van Eerd M, Lataster A, Hartrick C, Mekhail N, van Kleef M. Radiofrequency rhizotomy for facet syndrome. In: Huntoon MA, Benzon HT, Narouze S, eds. Spinal Injections and Peripheral Nerve Blocks. Philadelphia, PA: Elsevier/Saunders; 2012. Chapter 14. p. 148-163.

van Zundert J, Huntoon M, Patijn J, Lataster A, Mekhail N, van Kleef M. Cervical radicular pain. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 4. p. 18-30.

Vanelderen P, Szadek K, Cohen SP, De Witte J, Lataster A, Patijn J, Mekhail N, van Kleef M, van Zundert J. Sacroiliac joint pain. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 13. p. 96-102.

Venelderen P, Lataster A, Levy R, Mekhail N, van Kleef M, van Zundert J. Occipital neuralgia. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 8. p. 49-54.

Visconte V, Tiu RV. Rare bone marrow failure conditions. In: Raghavan D, ed. Textbook of Uncommon Cancer. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2012. Chapter 46. p. 637-646.

Vissers KCP, Besse K, Wagemans M, Zuurmond W, Giezeman MJMM, Lataster A, Mekhail N, Burton AW, van Kleef M, Huygen F. Pain in patients with cancer. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 23. p. 173-190.

Wackernagel W, Singh AD. Genetic aspects of uveal melanoma. In: Traboulsi EI, ed. Genetic Diseases of the Eye. 2nd ed. New York, NY: Oxford University Press; 2012. Chapter 48. p. 816-827.

Wolff A, Vanduynhoven E, van Kleef M, Huygen F, Pope J, Mekhail N. Phantom pain. In: van Zundert J, ed. Evidence-Based Interventional Pain Medicine : According to Clinical Diagnoses. Chichester: Wiley-Blackwell; 2012. Chapter 21. p. 160-167.

Yu JS, Haas-Kogan DA. General approach to radiation oncology. In: Packer RJ, Schiff D, eds. Neuro-Oncology. Chichester, West Sussex: Wiley-Blackwell; 2012. Chapter 4. p. 33-43.